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INTRODUCTION 
cellular cooperation During the Immune Response 
The cellular theory of immunity was developed in 1883 
by Elie Metchnikoff following his demonstration that 
macrophages ingested foreign bodies that were introduced into 
starfish larvae (1, 2). The subsequent discovery, in 1890, 
of soluble factors in serum that possessed antimicrobial 
properties (3) led to the identification of antibodies and the 
development of the humeral theory of immunity ( 4) . These 
discoveries led to the concept of a dualistic immune response, 
comprised of cellular and humeral elements. 
The involvement of lymphocytes in immunity was first 
recognized in the 1940s by the demonstration that lymphocytes 
were involved in antibody formation (5) and that they mediated 
the adoptive transfer of contact sensitivity (6), the 
tuberculin (delayed type hypersensitivity) reaction (7) and 
the allograft response (8). In the late 1950s and early 1960s 
it was discovered that two distinct types of lymphocytes 
mediated the humoral and cellular arms of the immune response. 
Lymphocytes mediating the humoral arm of the immune response 
were discovered following the observation that bursectomy in 
1 
2 
chickens led to the complete elimination of all antibody 
mediated responses, while leaving the allograft response 
intact (9, 10). Antibody production and the humoral arm of 
the immune response was therefore mediated by Bursa derived 
(B) lymphocytes. The lymphocytes that mediated the cellular 
arm of the immune response were discovered in similar manner, 
by the observation that neonatally thymectomized mice were 
unable to mount an allograft response (11). The cellular arm 
of the immune response was therefore mediated by thymocyte-
der i ved (T) lymphocytes. 
Subsequent studies revealed that the function of these 
two types of immune cells were not mediated entirely 
independently of each other. In the first example of cellular 
cooperation described for the immune response, various 
researchers in the late 1960s discovered that T cells were 
required for the optimal generation of antibodies from B cells 
( 12, 13), despite the prior demonstration that T cells by 
themselves do not secrete antibodies (14). Further 
investigation of the antibody response led to the discovery 
that a third cell, the macrophage, participated in this 
response (15). 
A requirement for cellular cooperation with macrophages 
was also described for the activation of T cells by foreign 
antigen. In the early 1970s, it became clear that T cells 
3 
differed in the manner by which they recognized antigen 
compared to B cells. Whereas B cells were able to recognize 
soluble antigen through membrane associated immunoglobulin 
molecules (16), T cells recognized antigen only when it was 
associated with class II major histocornpatibility (MHC) 
molecules expressed on the surface of histocompatible 
macrophages (17). Similar antigen presenting capacity has 
since been demonstrated for a number of other cell types, 
including B cells ( 18) , dendri tic cells ( 19) , and various 
members of the macrophage lineage (20, 21). Cells of the 
macrophage/monocyte lineage have more recently been shown to 
provide accessory functions during T cell activation distinct 
from their capacity to act as antigen presenting cells during 
T cell activation (31, 32). 
Further elucidation of macrophage accessory function 
during T cell activation was made possible following the 
characterization of the antigen specific T cell receptor (TCR) 
(22-27). The TCR was shown to be immunoglobulin-like in 
overall structure, its variable domains simultaneously 
recognizing both the antigen and self MHC molecules on the 
appropriate accessory cell (28). Following the 
characterization of this structure, reagents were developed 
that were able to dissociate the signalling events mediated 
via the TCR from the succession of signalling events required 
for T cells to become fully activated. In the current model 
4 
of T cell activation, the first T cell activation signal is 
provided by the MHC restricted recognition, through the TCR, 
of foreign antigen expressed on the surface of an antigen 
presenting cell (17, 29, 30). T cells triggered in this 
manner undergo necessary physiological changes that accompany 
the initial phase of T cell activation, although further 
activation of triggered T cells requires the presence of 
costimulatory molecules provided by an accessory cell (31, 
32). A rich source for a number of costimulatory molecules 
are cells of the myeloid lineage, such as the macrophage and 
the blood monocyte. In peripheral blood, monocytes serve as 
the principal accessory cell during T cell activation. During 
their antigen specific interaction with T cells, monocytes are 
capable of providing both signals required for T cell 
activation. In their dual capacity as antigen presenting 
cells and rich source of soluble and cell associated 
costimulatory molecules, monocytes provide both the antigen 
recognition signal and necessary second activation signal. 
Interleukin 1 
Interleukin 1 (IL-1) is a polypeptide cellular mediator 
that is produced after infection, injury or antigenic 
challenge. IL-1 was initially identified in many laboratories 
as distinct biological activities, later (34) recognized to 
be mediated by the same molecule. IL-1 is a polypeptide 
5 
hormone that mediates the systemic acute phase response 
towards microbial infection, inflammation and tissue injury. 
within hours after infection or injury, IL-1 gains access to 
the circulation and acts like a hormone to induce a broad 
spectrum of changes in such diverse systems as the neurologic, 
immune and metabolic systems. The neurologic effects of IL-
1 include the induction of fever (35), the induction of slow 
wave deep sleep (36), and the release of hypothalamic 
releasing factors (37). In the immune system, IL-1 plays an 
important role in initiating the immune response (31, 32, 38) 
and promoting tumor killing (39). Included among the 
metabolic activities of IL-1 are the induced synthesis of 
hepatic acute phase protein (40), serum metal ion depletion, 
neutrophilia (41) and fibroblast proliferation (42). Il-1 
also induces the synthesis of the vasodilators platelet 
activating factor and prostaglandins E2 and I 2 (43). These 
examples of the cellular effects of IL-1, which represent only 
a small fraction of its reported properties, demonstrate that 
IL-1 exhibits pleiotropic effects in many different cell 
types. An understanding of the entire spectrum of systemic 
effects mediated by IL-1 has led to a concept of IL-1 as the 
key modulator of an integrated response by the body towards 
infectious challenge or inflammation (44). 
The principal source of IL-1 during an infectious 
challenge is the activated blood monocyte (45, 46}. Other 
6 
sources of IL-1 at the site of inflammation include tissue 
macrophages (47), vascular endothelial cells (48) and vascular 
smooth muscle cells (49). The pathways by which monocytes 
secrete IL-1, although still not completely understood, have 
become clearer following the recent cloning of the genes 
encoding IL-1. 
A genetic analysis of cloned human IL-1 led to the 
conclusion that IL-1 was encoded by two distinct IL-1 genes, 
termed IL-1 a and IL-1 /3 ( 50-54). Sequence comparisons 
between the coding regions of IL-1 a and IL-1 /3 revealed two 
remarkable properties of the two encoded IL-1 protein 
products. First, despite the previously discussed hormonal 
properties of IL-1, neither IL-1 gene encoded a protein 
containing a leader sequence common to most secreted 
polypeptide hormones. Second, IL-1 a and IL-1 /3 exhibited 
only 26 % nucleotide sequence homology, yet they were both 
cloned on the basis of an identical biological activity that 
they encoded (50). These findings at the genetic level have 
extensive implications on the mechanisms by which IL-1 is 
secreted and how IL-1 mediates its biological activities. 
At the level of IL-1 secretion, the absence of a leader 
sequence explained the previous observation that the majority 
of IL-1 in activated monocytes was present intracellularly 
(55). IL-1 a and IL-1 /3 were both shown to accumulate as 
7 
biologically active 31 kD IL-1 precursors in the cytoplasm of 
rnonocytes activated by the bacterial. cell membrane product, 
lipopolysaccharide (LPS). At this point, the processing steps 
leading to the formation of mature IL-1 proteins of each 
species diverged. Mature forms of IL-1 have been detected 
both in the extracellular compartment and associated with the 
outer membrane compartment of activated monocytes (56, 57). 
IL-1 {3 1 which constitutes the predominant secreted form of IL-
1 (58), was released from an intracellular membrane 
compartment to the mature 17 kD secreted product by a poorly 
understood process that involved proteolytic cleavage by an 
unknown serine protease, a process inhibitable by the serine 
protease inhibitor PMSF (59). IL-1 a precursors appeared to 
be translocated to the cell surface, as 31 kD or 23 kD 
proteins, by a glycosylation dependent attachment to lectin 
molecules on outer plasma cell membranes (60). The observed 
partitioning of mature IL-1 molecules, between membrane and 
extracellular compartments, suggested that these two products 
could mediate both short and long range effects. These 
studies have demonstrated that multiple posttranslational 
processing steps and multiple levels at which IL-1 may be 
regulated are involved in the synthesis of mature IL-1 by 
activated monocytes, as might be expected for a molecule with 
such potent systemic effects. 
IL-1 a and IL-1 {3 were shown during their cloning to 
8 
mediate identical biological activities, despite only 26 % 
nucleotide sequence-homology (50). To examine the mechanism 
by which two genes with such limited homology could encode 
products with similar biological activities, both full length 
genes were transfected and expressed in a mammalian cos cell 
line (61). Both full length genes encoded protein products 
with indistinguishable effects on T cells. Deletion mutants 
demonstrated that truncated proteins from each IL-1 gene, 
representing a conserved stretch of only 62 out of a total 269 
amino acids (23 %}, exhibited 50 % of the total biological 
activity of full length proteins. These findings explained 
how two proteins with apparently divergent nucleotide 
sequences could mediate similar biological effects. 
The genetic regulation of the IL-1 genes remains poorly 
understood. A comparison between IL-1 a and IL-1 f3 gene 
regulation has not been performed. However, IL-1 f3 was 
demonstrated to be the major species of IL-1 induced at the 
mRNA level in LPS activated blood monocytes, comprising > 90 
% of total IL-1 mRNAs (50) and a remarkable 5 % of the total 
cellular mRNA complement ( 62) . These observations at the 
level of genetic regulation of IL-1 therefore supported the 
previous demonstration that blood monocytes were capable of' 
producing large quantities of IL-1 during an infectious 
challenge. 
9 
Role of IL-1 in T Cell Activation 
The first signal required for T cell activation 
involves triggering via the TCR, mediated either through the 
MHC restricted recognition of antigen on the surface of the 
antigen presenting cell or, experimentally, by antiboies 
directed against the TCR complex. Effective TCR triggering 
initiates a cascade of intracellular activation events, 
including phosphatidyl inositol turnover (63), the subsequent 
release of ca2+ from intracellular stores ( 64) / partial protein 
kinase c (PKC) translocation (65) and IL-2 receptor expression 
(66). These biochemical events, although required to prime 
T cells for activation, do not by themselves provide 
sufficient triggering stimulus for T cells to become fully 
activated. T cells triggered through the TCR require the 
presence of the accessory cell derived costimulatory 
molecules / to provide the necessary second signal for the 
elaboration of the autocrine growth factor IL-2 and induction 
of IL-2 dependent clonal expansion (67). 
IL-1 was the initial cytokine demonstrated to possess 
costimulatory properties during T cell activation (68, 69). 
In these studies, Gery and Waksman recognized that an 
essential component of macrophage accessory cell function 
during T cell activation was their ability to secrete the 
cytokine lymphocyte activating factor (LAF), later renamed 
10 
IL-1· Following the initial findings of Gery and Waksman, 
efforts were directed towards establishing whether an 
obligatory requirement for IL-1 during T cell activation 
existed. 
Early reports, which demonstrated an obligatory 
requirement for IL-1 during T cell activation, were performed 
in experimental systems that were not rigorously depleted of 
monocytes. In these studies, IL-1 was reported to replace the 
APC requirement for the induction of IL-2 receptors, IL-2 and 
T cell proliferation (70, 71). Unacceptably high 
proliferations induced by monocyte dependent T cell mitogens 
in these experiments showed that purified T cell populations 
were contaminated with low numbers of monocytes. The 
interpretation derived from these studies must therefore be 
modified from an initial conclusion that IL-1 was an obligate 
requirement for T cell activation to the conclusion that, in 
the presence of limiting numbers of accessory cells, IL-1 
could reconstitute T cell responses. 
Conclusions arguing against an obligatory role for IL-
1 in T cell activation were drawn from subsequent reports that 
demonstrated the IL-1 independent activation of T cells. 
Accessory cells of the dendritic cell lineage have been 
demonstrated to provide costimulatory molecules which, in the 
absence of IL-1, lead to complete activation of T cells (72). 
11 
subsequent experiments showed that a requirement for 
costimulatory signals, including IL-1, could be bypassed 
al together in experimental systems in which T cells were 
activated by solid phase anti-CD3 monoclonal antibody (anti-
CD3 m.Ab) immobilized at high densities to culture plates. In 
these experiments, human T cells were activated independently 
of IL-1 and other accessory cell derived costimulatory 
molecules following prolonged 
intracellular Ca~ levels (73-75) . 
(> 2 h) elevations of 
These studies demonstrated 
that the requirement for a soluble second signal could be 
obviated in vitro by saturating and cross-linking sufficient 
TCRs through immobilized anti-TCR complex monoclonal 
antibodies. In vivo, however, it is unlikely that occupancy 
of TCRs by foreign antigen ever exceeds 10 %, thus suggesting 
that there may be an absolute requirement for accessory cell 
derived costimulatory molecules in vivo (76-78). Although 
these in vitro experiments excluded an obligate requirement 
for IL-1 during T cell activation, activation conditions were 
not necessarily relevant to the activation of T cells under 
physiological conditions. 
More recently, investigators have concentrated on 
obtaining a clearer understanding of the true costimulatory 
role of IL-1 during T cell activation under conditions that 
are physiologically relevant. Such an understanding has been 
provided by studies which assessed the costimulatory 
12 
properties of recombinant IL-1 during the activation of highly 
purified populations of unprimed human T cells, triggered 
through the TCR complex with phytohemagglutinin (PHA) or anti-
CD3 mAb. In populations of unprimed tonsillar T cells, 
rigorously depleted of monocytes (< 0.1%), Houssieau and Van 
snick (79) demonstrated that IL-6, a second monocyte derived 
cytokine, dramatically synergized with IL-1 to stimulate 
proliferation of T cells triggered with PHA. In a subsequent 
investigation (80), these authors demonstrated that the 
synergy between IL-1 and IL-6 derived from their complementary 
effects on the production of and response to IL-2 by T cells. 
IL-1 played the preponderant role in the induction of IL-2, 
whereas IL-6 was required, in addition to IL-1, for optimal 
IL-2 responsiveness. Further investigation by these authors 
revealed that IL-6 mediated its actions by moving resting T 
cells from G0 to G1 , where they become more responsive to the 
small amounts of IL-2 induced by IL-1. Similar results were 
reported by Holsti and Raulet (81), employing highly purified 
human CD4+ T cells triggered with immobilized anti-CD3 mAb. 
In this investigation, CD4+ T cells, isolated by cell sorting, 
were provided with the TCR triggering signal by carefully 
controlled doses of anti-CD3 mAb. CD4+ T cells triggered in 
this manner also demonstrated the synergistic induction of T 
cell proliferation by IL-1 and IL-6, mediated via an induction 
of IL-2 secretion. These studies have therefore delineated 
a principal role of IL-1 during the induction of T cells. 
13 
Although IL-1 does not mediate its effects alone during T cell 
activation, it acts synergistically with IL-6 and is required 
for the critical elaboration of the autocrine growth factor 
IL-2, resulting in the IL-2 induced clonal proliferation of 
triggered T cells. 
A role for membrane IL-1 in the activation of T cells 
has been investigated in several previous reports. Initial 
studies with preactivated, fixed mouse macrophages 
demonstrated that a membrane component, inhibitable by anti-
IL-1 antiserum, was capable of providing the necessary 
costimulatory signals to antigen primed T cell clones (56). 
These findings were extended to unprimed human T cells (82), 
triggered through immobilized anti-CD3, thereby demonstrating 
that membrane IL-1 a on paraformaldehyde fixed monocytes was 
capable of providing all costimulatory signals necessary to 
stimulate proliferation of triggered T cells. An important 
role for membrane IL-1 as a costimulatory molecule in T cell 
activation has therefore been demonstrated by experimental 
observations of anti-IL-1 inhibitable costimulation of T cells 
by fixed macrophages or monocytes. However, these studies do 
not rule out the participation of other membrane associated 
costimulatory molecules in addition to membrane IL-1, such as 
the cellular adhesion molecules, during T cell activation. 
Induction of cellular adhesion molecules may represent 
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an indirect mechanism by which IL-1 mediates its costimulatory 
effects during T cell activation. In this model, IL-1 
transduces an intracellular signal leading to the induction 
of adhesion molecules on the monocyte cell surface, or it 
promotes expression of adhesion molecules on the T cell 
surface. In support of such a model, the adhesion partners 
LFA-3 and CD2, on the monocytes and T cell surface 
respectively, have been demonstrated to exhibit costimulatory 
properties during T cell activation (83, 84). 
Several mechanisms by which IL-1 mediates its 
costimulatory properties during T cell activation have been 
identified. Most previous work has concentrated on 
characterization of the signal transduction pathways 
stimulated by IL-1 to mediate its effects on IL-2 synthesis, 
which represents the pivotal event leading to the clonal 
expansion of appropriately triggered T cells expressing IL-2 
receptors. These studies have resulted in the identification 
of two signal transduction pathways through which IL-1 can 
mediate its costimulatory effects at the level of IL-2 
production in T cells. 
A phorbol ester mediated signal transduction pathway 
has been identified in T cells that stimulates high levels of 
IL-2 secretion. A number of studies showed that IL-1 did not 
mediate its costimulatory properties in T cells through the 
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classic phorbol ester mediated signal transduction pathways, 
consisting of phosphatidyl inositol hydrolysis and protein 
kinase C (PKC) activation (85). Although hydrolysis of 
phosphatidyl inositol has been ruled out as a component of 
IL-1 signal transduction, several recent studies have reported 
that IL-1 induced the hydrolysis of another phospholipid, 
phosphatidylcholine, resulting in the production of diacyl 
glycerol, the same second messenger generated by phosphatidyl 
inositol hydrolysis (86). In other parallels to the phorbol 
ester induction pathway, IL-1 was also shown to mediate its 
effects on IL-2 induction by stimulating a protein kinase 
distinct from PKC (87, 88). Experimental evidence therefore 
supports transduction of IL-1 costimulatory signals by a 
pathway employing components of the classic phorbol ester 
signal transduction pathway. IL-1 was demonstrated to 
stimulate a second, cyclic-AMP (c-AMP) dependent signal 
transduction pathway (89). These reports demonstrated that 
IL-1 induced a c-AMP dependent protein kinase, which may 
represent the same non-PKC protein kinase previously 
identified to transduce IL-1 costimulatory signals during T 
cell activation. The c-AMP dependent protein kinase was shown 
to transduce its IL-2 stimulatory effects at the level of the 
IL-2 promoter. Recent analysis of the IL-2 promoter region 
has allowed diverse signals originating from separate 
receptors and transduced by the separate pathways previously 
described to be integrated at the level of the IL-2 gene (90) . 
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Direct evidence has been obtained that IL-1 mediates 
its costimulatory effects at the level of the IL-2 promoter 
(91) . A human IL-2 promoter fused to the chloramphenicol 
acetyl-transferase (CAT) indicator gene was used to transfect 
LBRM cells and identify an IL-1 responsive element within the 
IL-2 promoter. This element contained a 12 bp motif, 
previously identified as a component of the phorbol ester TPA 
response element (TRE) (92), that was specifically recognized 
in gel retardation assays by its appropriate nuclear factor, 
AP-1. These authors also examined the ability of IL-1 to 
induce transcription of the two oncogenes, c-jun and c-fos, 
that encoded the two major protein components of the AP-1 
factor (93, 94). These studies revealed that stimulation with 
IL-1 induced strong transcription from the c-jun and to a 
lesser extent the c-fos gene, whereas stimulation with PHA 
induced transcription from the c-fos, but not c-jun, gene. 
De novo protein synthesis was not required for transcription 
from either oncogene, indicating that IL-1 induced 
transcription of IL-2 in T cells triggered with PHA occurred 
through the de !1QYQ protein synthesis of the c-jun component 
of the AP-1 factor. These observations provided direct 
evidence for a mechanism whereby IL-1 transduced its T cell 
costimulatory properties at the level of increased 
transcription of the IL-2 gene, mediated through the induced 
binding of AP-1 to the TRE element in the IL-2 promoter. 
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Indirect evidence also exists that IL-1 may mediate its 
costimulatory effects by activating the kappa B-like enhancer 
recently identified within the IL-2 promoter (95). IL-1 was 
shown to activate the kB-like enhancer in a pre-B cell line 
via the generation of functional NF-kB DNA binding proteins 
(96). Activation of functional NF-kB and induction of the kB-
like enhancer were dependent upon a cAMP dependent protein 
kinase activity. IL-1 therefore mediated its kB-enhancer 
activating properties via its stimulation of the cAMP second 
messenger pathway. Collectively, these studies suggested that 
costimulatory effects of IL-1, even when transduced by diverse 
second messenger pathways, may be integrated at the level of 
the IL-2 promoter through the TRE and NF-kB response elements. 
The TRE and NF-kB response elements have been found in 
the promoters of many genes in multiple cell types, thereby 
providing a rationale to explain the spectrum of di verse, 
systemic cellular effects described for IL-1. In light of the 
potent effects mediated by IL-1 following an immune challenge, 
both at the systemic level and at the level of initiation of 
the immune response, it is particularly important to 
understand the mechanism by which IL-1 production is initiated 
and regulated during an immune response. 
Induction of IL-1 During an Immune Response 
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In view of the potent biologic activities previously 
described for IL-1, it is of interest to understand the 
mechanisms that regulate its production during an immune 
challenge. The activated blood monocyte has been shown to be 
the principal source of IL-1 (45, 46). Circulating blood 
monocytes have been shown by in situ hybridization analysis 
not to constitutively express IL-1 mRNA (97). They elaborate 
IL-1 during phagocytic responses towards any number of 
particulate stimuli, such as allogeneic erythrocytes or latex 
beads (44). Monocytes are also stimulated to produce IL-1 in 
response to bacterial antigens, such as LPS, which possess 
intrinsic IL-1 inducing properties (98). However, monocytes 
do not synthesize IL-1 in response to the spectrum of self 
antigens that they encounter during routine homeostatic 
functions in peripheral blood (99, 100). Monocytes produce 
IL-1 in response to soluble antigens only during the course 
of an immune response to foreign antigen (98). Therefore, a 
prerequisite for the induction of IL-1 during an immune 
response is the ability to distinguish self and non-self 
soluble antigens. However, it has been well established that 
monocytes lack the ability to distinguish self and non-self 
antigens, processing and presenting each with equal efficiency 
(99, 100). 
The inability of monocytes to distinguish between self 
19 
and non-self antigens during processing has been well 
documented. Winchester and Mitchison (99) examined the 
ability of macrophages from two H-2k mouse strains to process 
and present strain specific forms of the F protein. F protein 
occurs in H-2k mice in two allelic forms, F.l and F.2, which 
elicit a strong T cell dependent antibody response in strains 
exhibiting the opposite F type. These studies demonstrated 
that macrophages pulsed with either the self or foreign F 
protein were able to elicit identical responses in T cells 
from the opposite F type. A second study, by Lorenz and Allen 
(100), employed T cell hybridomas specific for hemoglobin in 
the context of I-Ak (Hb/I-Ak) to detect the presence of Hb/I-
Ak complexes constitutively expressed on resident peritoneal 
macrophages. Collectively, these studies demonstrated that 
monocytes processed and presented self and non-self antigens 
with equal efficiency and that self antigens were 
constitutively presented on the monocyte surface in healthy 
mice. 
In view of the inability of monocytes to distinguish 
between self and non-self proteins, a logical proposal is that 
the IL-1 inductive signal in vivo is provided by the antigen 
specific T cell during its interaction with the presenting 
monocyte. The T cell, which possesses the molecular 
recognition machinery necessary for self/non-self 
discrimination (22-27), would signal the monocyte, which lacks 
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this discriminatory capacity, to elaborate IL-1. According 
to this hypothesis, recognition through the TCR of foreign 
antigen triggers the transduction of an IL-1 inductive signal 
from the T cell to the monocyte, thereby stimulating 
production of the IL-1 costimulatory molecule and enabling 
clonal proliferation of the triggered T cell. 
The earliest studies investigating IL-1 induction 
during an immune response were performed in peritoneal 
macrophages of mice immunized in vivo with infectious agents, 
particulate substances and T cell mitogens (101, 102). These 
studies revealed that the secretion of IL-1 by macrophages was 
enhanced following exposure to soluble products of activated 
T lymphocytes, thereby identifying the existence of reciprocal 
stimulatory signals transferred between lymphocytes and 
macrophages. These findings were subsequently extended in 
human in vitro cell systems, which demonstrated secretion of 
IL-1 by the human monocytic 0937 line following exposure to 
cell free supernates of mitogen activated human T cells (103, 
104). Dinarello and Kent (105) also reported detection of a 
soluble IL-1 inducing factor in the supernates of a primary 
human allogeneic MLR. This observation confirmed that T cells 
activated directly through their TCR in the MLR response, 
could generate IL-1 inductive signals during a primary immune 
activation. 
induction 
A weakness of these early reports, which assessed 
of IL-1 at the secreted level, was tl)at they 
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utilized the thymocyte comitogenesis IL-1 assay (106), which 
does not distinguish between IL-1, IL-6 or IL-2 activities. 
Recognizing the limitations of the thymocyte 
comitogenesis assay, subsequent studies by Weaver and Unanue 
(107} and Wasik and Beller (108) assessed induction of IL-1 
at the level membrane associated IL-1 (mIL-1). mIL-1 activity 
was assessed on paraformaldehyde fixed macrophage membranes 
and was therefore not subject to the same artifact as secreted 
IL-1 in the comitogenesis assay. In these experiments, Weaver 
and Unanue detected a cell contact mediated mIL-1 inductive 
signal generated by antigen specific T cell clones. The cell 
contact mediated signal was antigen specific, MHC restricted, 
and was generated in the absence of de D.QYQ protein synthesis. 
A similar macrophage mIL-1 inductive signal, generated by T 
cell clones that respond to syngeneic MHC determinants on 
accessory cells in the absence of antigen, was reported by 
Wasik and Beller (108). This mIL-1 inductive signal was 
mediated by direct cell contact, was generated independently 
of T cell protein synthesis and remained intact following 
paraformaldehyde fixation. The kinetics of induction of mIL-
1 were consistent between these two studies and showed 
detectable mIL-1 activity as early as 4 h following addition 
of T cells to macrophages. In addition, through the use of 
autoreactive T cell clones restricted to class I or class II 
22 
MHC molecules on macrophages, Wasik and Beller were able to 
demonstrate that the IL-1 inductive signal could be transduced 
by either class I restricted or class II restricted T cell 
clones. This observation enabled these authors to infer that 
the T cell IL-1 inductive signal was transduced either by both 
class I and class II restricted associative recognition 
elements on the surface of T cells or by non-MHC-restricted 
cell surface molecules. In summary, these two studies 
demonstrated that T cell clones generated a macrophage mIL-1 
inductive signal, which was transduced through direct cell 
contact, independent of protein synthesis and was not 
exclusively mediated during the class II restricted 
interaction between T cells and macrophages. 
A limitation to the studies of Weaver et al. (107) and 
Wasik et al. (108), was that these investigators examined the 
IL-1 inductive signals generated by T cell clones which were 
previously primed and maintained in the presence of antigen. 
Therefore, although these reports supported a role for T cells 
in the induction of IL-1 by macrophages, it was not clear from 
these studies whether previous activation of T cells was 
required for acquisition of this IL-1 inductive property. 
Whether previous activation of T cells is required for 
the generation of IL-1 inductive signals remains 
controversial. Bhardwaj and Steinmann (109) have employed 
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human monocytes to address whether the induction of IL-1 can 
occur in primary as well as secondary immune responses. These 
studies supported the specific immunodetection of IL-1 p at 
the secreted level with assessments of intracellular IL-1 p 
levels, which provided an early measure of IL-1 production. 
ouring primary immune activation towards anti-CD3 mAb, these 
studies demonstrated inconsistent patterns of induction of 
intracellular monocyte IL-1 and secreted IL-1 p. However, 
IL-1 was consistently induced during secondary mitogenic 
responses, employing anti-CD3 activated T cells blasts 
isolated from dendritic cell clusters. These authors 
therefore concluded that induction of IL-1 was a feature of 
secondary but not primary immune responses. A pattern of IL-
1, detectable at the secreted but not intracellular level in 
response to the anti-CD3 mitogen, suggested technical 
limitations inherent in these studies for detection of 
intracellular monocyte IL-1. Furthermore, these studies are 
difficult to reconcile with the reported induction of IL-1 in 
other primary mitogenic responses in the human, assessed at 
the level of secreted IL-1 (110-112) and IL-1 a and p mRNAs 
(113). Whether or not induction of IL-1 can occur during 
primary mitogenic responses therefore remains unclear. It 
should be noted that no prior studies have adequately 
addressed the question whether previous activation of T cells 
is required for generation of IL-1 inductive signals, as the 
mitogenic responses previously utilized stimulate both naive 
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and previously primed T cells in peripheral blood. 
In addition to cell contact dependent signals, a second 
type of T cell IL-1 inductive signal has been identified which 
mediates induction of IL-1 through soluble T cell lymphokines. 
weaver and Unanue have characterized a soluble mIL-1 inductive 
signal generated by T cell clones following mitogenic 
stimulation by concanavalin A (Con A) in the presence of 
macrophage membranes (114). This T cell signal, designated 
IL-1 inducing factor (IL-1 IF), was dependent upon protein 
synthesis for its generation and was shown to be related to 
the TNF family of lymphokines. Transduction of the mIL-1 
inductive signal by IL-1 IF was non-MHC restricted. Several 
other investigators have confirmed the role of soluble T cell 
factors during the induction of IL-1 in human blood monocytes. 
Recombinant preparations of the cytokines IL-2 (115, 116) and 
TNF-a (48, 117) have been identified to exhibit de novo IL-1 
mRNA inductive properties, while IFN- has been shown to 
augment expression of IL-1 mRNA levels (117). These recent 
studies have shifted experimental strategy towards 
measurements of IL-1 induction at the level of rnRNA 
expression. In light 
processing steps that 
of the multiple posttranslational 
have been identified during the 
production of mature IL-1 protein in monocytes, assessments 
of IL-1 induction at the mRNA level provide the most suitable 
level at which to detect early IL-1 inductive .signals. 
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collectively, these studies demonstrated that soluble T cell 
derived cytokines could induce monocyte IL-1 mRNAs in an MHC 
unrestricted manner. 
The T cell derived cytokines, previously identified to 
possess IL-1 inductive properties, are unlikely to represent 
the initial IL-1 inductive signal for the blood monocyte 
during an immune response to foreign antigen. These IL-1 
inducing cytokines are all produced at a later stage of the 
immune response and are required at the upper end of their 
physiological dose range. It is more likely that these IL-1 
inducing cytokines play a role in the non-specific 
amplification of IL-1 production from bystander monocytes 
later in the immune response. The discovery of a pathway that 
can lead to a non-specific amplification of IL-1 production 
during an immune response reinforces the need to better 
understand the events at the site of the antigen specific 
interaction with T cells and monocytes that initially leads 
to the induction of IL-1 in monocytes. 
It is clear from these previous reports that only 
limited information is available concerning the signals that 
regulate induction of IL-1 during an immune response. Heavy 
reliance has also been placed in previous studies on the use 
of previously activated T cells or T cell clones. The human 
system presents the advantage that unprimed T cells may be 
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isolated from peripheral blood and polyclonally activated 
through their TCR complex in the well characterized anti-CD3 
mitogenesis model (118). 
Anti-CD3 as a Model of TCR Triggered T Cell Activation 
The anti-CD3 mitogenesis model in humans provides an 
experimental model that permits the polyclonal activation of 
peripheral blood T cells in a manner that is functionally 
analogous to a primary immune response (118). The 
experimental model employs antibodies directed against the CD3 
signalling moiety of the TCR complex to mimic the signal 
provided by the MHC restricted recognition of foreign antigen 
through the TCR. The activation requirements of T cells 
during anti-CD3 mitogenesis are the same as those previously 
described for an antigen specific immune response (119). 
Effective triggering through the TCR in this model 
demonstrates a requirement for monocytes, which cross link 
CD3/anti-CD3 complexes on the surface of the T cell via 
monocyte Fe receptors ( 119} . Triggering through the TCR 
results in the same biochemical events that are mediated by 
recognition of foreign antigen through the TCR, including 
elevation of intracellular ca• levels ( 64), phosphatidyl 
inositol hydrolysis (63), partial PKC translocation and IL-2 
receptor expression (66). Effectively triggered T cells 
demonstrate a requirement for additional monocyte derived 
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costimulatory signals before they elaborate IL-2 and undergo 
rL-2 induced clonal proliferation (67). 
This dissertation employed the anti-CD3 mitogenesis 
model to investigate the T cell mediated induction of IL-1 
mRNA and secreted activity in human monocytes. 
The major objectives of this investigation were: 
(1) To determine whether induction of human monocyte IL-1 
mRNAs occurred during anti-CD3 mediated TCR triggering and 
(2) To characterize the T cell signals required for this 
induction. 
MATERIALS AND METHODS 
,2.DNA Probes 
cDNAs for the human IL-1 a, human IL-1 ~, human IL-6 
and mouse hi stone H3 . 3 genes were provided by Dr. Masaaki 
Yamada of the Dainippon Pharmaceutical Co., Ltd. (Osaka, 541 
Japan), Dr. Donald Carter of the Upjohn Corp. (Kalamazoo, MI), 
the American Type Culture Collection (ATCC; Rockville, MD) and 
Dr. William Marzluff (Florida State University, Tallahassee, 
FL) respectively. 
The IL-1 a probe was contained in a 1.6 kb EcoRI/PstI 
fragment in plasmid pHN-02 and included nucleotides 455-872 
of the human IL-1 a coding region and 3' untranslated material 
( 53) • The IL-1 ~ probe was contained in a 546 bp PstI 
fragment in plasmid pIL-1 14 and included nucleotides 357-830 
of the human IL-1 ~ coding region (50). The IL-6 probe was 
contained in 1.16 kb EcoRI fragment in plasmid pCSF309 and 
corresponded to nucleotides 1-1120 of the human IL-6 coding 
region (120). The histone H3.3 probe was contained in a 2.5 
kb HindIII fragment in plasmid MH921 and included the entire 
405 bp coding region and flanking genomic sequences of the 
H3.3 mouse histone gene (121). 
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cDNA inserts were excised from vector DNA by digestion 
with restriction endonucleases (BRL Life Technologies Inc., 
Gaithersburg, MD.). For IL-1 ~ cDNA, for example, 10 µg pIL-
1 14 was digested at 37 • C for 1 h with the manufacturer 
recommended units of the restriction endonuclease PstI. 
Digested DNA was loaded in the presence of 67 mg/ml sucrose 
loading buff er and size fractionated by electrophoresis on 1 
% agarose gels (SeaKem ME; FMC Bioproducts, Rockland, ME). 
Gels were made up in electrophoresis running buffer, 
consisting of 40 mM Tris-acetate (pH 6.8), 1 mM EDTA, and 0.5 
µg/ml ethidium bromide. cDNA inserts were visualized on a UV 
transilluminator, sized with respect to HindIII digested 
lambda DNA size markers and cut out of the gel. Gel fragments 
containing cONAs were weighed, boiled at 0.3 g/ml in H20 and 
stored frozen at - 2o·c prior to use. 
For use as probes in these studies, 25 ng cDNA was 
labelled with 50 µCi a 32P-dCTP ( 3000 Ci/mmol, NEN Research 
Products, Boston, MA.) employing an oligolabelling kit 
according to manufacturers specifications (Pharmacia LKB 
Biotechnology Inc., Piscataway, NJ). Specific activities were 
> 5 x 107 CPM/µg DNA. The labelling reaction was terminated 
by the addition of 20 rnM EDTl\ and unincorporated radionuclides 
were removed by size exclusion column chromatography employing 
Sephadex GSO (Boehringer Mannheim Biochemicals, Indianapolis, 
30 
IN) • Incorporation of a-
32P-dCTP into cDNAs was determined by 
precipitation of 1 ng DNA in the presence of 1 µg yeast tRNA 
(BRL Life Technologies, Inc.) with 1 ml 10 % TCA and a 10 min. 
incubation on ice. The TCA precipitate was harvested onto 
filters, dried and counted in organic scintillation cocktail 
pa20 Complete Counting Cocktail, Research Products 
International, Mount Prospect, IL) using an LKB 1219 Rackbeta 
scintillation counter ( LKB Instruments Inc. , Gaithersburg, 
MD). 
Normal Human Serum 
Normal human serum was collected from peripheral blood 
of 22 normal human donors. Peripheral blood was incubated at 
37°C for 1 h, allowed to clot for 16 h at 4•c and serum was 
collected following centrifugation. Serum was pooled, heat 
inactivated at 56°C for 30 min and sterile filtered through 
a 0.45 µ filtration unit (Becton Dickinson Labware, Lincoln 
Park, NJ) . Normal human serum was stored in aliquots at -
20°C prior to use. 
Cell Lines 
The LBRM-33-1A5 mouse thymoma was obtained from the 
ATCC and was maintained in RPMI 1640 (Mediatech, Herndon, VA) 
supplemented with 15 % defined FCS (Hyclone Laboratories, 
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Logan, UT), 2 mM 1-glutamine and 25 µM P-2-mercaptoethanol. 
The IL-2 dependent cell line CTLL-20.J was maintained in RPMI 
1640 containing 10 % FCS (10 % FCS-RPMI), 2 mM 1-glutamine and 
so µM p-2-mercaptoethanol. The KT69-7 hybridoma, secreting 
the anti-C04 antibody KT69-7 (122), was provided by Dr. T. 
Mohanakumar (Washington University School of Medicine, St. 
Louis, MO). Hybridoma cell lines L243, W6/32, 6303 and OKTB 
were obtained from the ATCC and were maintained in 20% FCS-
RPMI, supplemented with 2 mM 1-glutamine. 
Monoclonal Antibodies 
Antibodies were isolated from supernates of the 
monoclonal antibody secreting hybridomas L243, W6/32, 6303, 
OKTB and KT69-7. Supernates were collected from cultures 3 
days after the most recent feeding. Supernates were 
centrifuged at 10,000 x g for 20 min and adjusted to 40 % 
(vi y) (NH4 ) 2S04 with a saturated solution of (NH4 ) 2so4 , pH 7. 5. 
Precipitates were harvested after 1 h of incubation on ice by 
centrifugation at 10, ooo x g for 20 min, dissolved in a 
minimal volume of deionized water and dialyzed extensively 
against phosphate buffered saline, containing 150 mM NaCl, and 
10 mM phosphate (pH 7.2). The concentration of protein in 
each antibody preparation was determined using the Bradford 
calorimetric assay (Bio Rad Laboratories, Richmond, CA) (123). 
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Antibodies obtained commercially included purified MOPC 
21 antibody (IgG1 : Sigma Chemical Company), purified UCHLl 
antibody (Dakopatts, Glostrup, Denmark), phycoerythrin (PE) 
conjugated polyclonal goat anti-mouse IgG28 antibody (Fisher 
scientific, Pittsburgh, PA) and fluorescein isothiocyanate 
( FITC) conjugated polyclonal F (ab') 2 goat anti-mouse IgG 
F(ab') 2 antibody (Organon-Teknika, Cappel Research Reagents, 
west Chester, PA) were obtained commercially. Anti-CD3 mAb 
(OKT3, IgG28 : Ortho Pharmaceutical Co., Raritan, NJ) was 
obtained from the Loyola Medical Center Pharmacy. PE 
conjugated anti-HLA-DR, anti-Leu M3, anti-Leu 2a and FITC 
conjugated anti-Leu 3a&b, anti-Leu 4, anti-Leu 5, anti-Leu 18 
and unconjugated anti-CDS (Leu 1), dialyzed in Hanks balanced 
salts solution (HBSS) to remove cytotoxic preservatives prior 
to use in cell cultures, were purchased from Becton-Dickinson. 
Cell Populations 
a. Isolation of Monocytes and T Cells 
Leukocytes were obtained from normal volunteer donors 
by leukapharesis or phlebotomy. Leukapharesis preparations 
enriched for the mononuclear cell fraction were collected in 
the presence of citrate as an anticoagulant. Whole peripheral 
blood was collected in the presence of 10 U/ml preservative 
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free heparin as an anticoagulant. For the collection of 
peripheral blood mononuclear cells (PBMCs), leukapheresis 
preparations or heparinized whole blood were diluted with an 
equal volume of HBSS and layered onto ficoll-hypaque gradients 
(LSM, density 1.077 - 1.080 g/ml; Organon Teknika Corporation, 
ourham, NC). Following centrifugation for 20 min. at 500 x 
g, the PBMC fraction was isolated from the ficoll interface 
and washed three times in ice cold HBSS containing 5 % FCS. 
For isolation of monocytes and T cells, PBMCs were 
fractionated by density on continuous Percell gradients. 
continuous Percell gradients were prepared by centrifugation 
of 1.075 g/ml iso-osmotic Percell in 40 ml screw cap 
polycarbonate tubes at 30,000 x g for 10 min at 22·c. Density 
marker beads were employed to monitor densities of the 
resulting Percell gradients. The densities of resulting 
gradients ranged from 1.033 g/ml at the top of the centrifuge 
tube to 1.098 g/ml at the bottom. 
PBMCs were fractionated by centrifugation over 
continuous Percell gradients (4 x 108/tube) at 500 x g for 30 
min. Monocyte enriched cell preparations were collected from 
the low density Percoll fraction (1.045-1.062 g/ml), washed 
three times in HBSS containing 5% FCS and adhered to 150 mm 
tissue culture dishes (Nunc # 683 81, Rupp & Bowman Co., 
Shaumburg, IL) in 5% human serum-RPM! 164 o, at 5 x 107 
cells/plate for 2 h at 37°C. 
34 
Purified monocyte lawns were 
obtained by removal of non-adherent cells by four vigorous 
washes with prewarmed HBSS. For double chamber well 
experiments, monocytes were allowed to adhere to the lower 
and/or upper chambers of 24 mm Transwells (0.4 µm pore size, 
costar, Cambridge, MA), employing the same wash procedures 
described above for conventional plates. Purity of monocytes 
was routinely confirmed by flow cytometric analysis of HLA-
DR, CD14 and CD2 cell surface marker expression and 
reconstitution of functional responses by T cells. 
T lymphocytes, collected from the high density Percell 
fraction (1.070-1.080 g/ml), were depleted of adherent cells 
by passage through nylon wool columns. Nylon wool (Cellular 
Products Inc., Buffalo, NY) was washed by five cycles of 
boiling for 10 min in deionized H2o followed by air drying. 
Combed nylon wool was loosely packed into 60 ml syringes at 
3 g/syringe and autoclaved. Prior to use, columns were washed 
with 100 ml 10 % FCS-RPMI, containing 2 mM 1-glutamine and 50 
µg/ml gentamycin, to remove air bubbles. Columns were drained 
and equilibrated in fresh 10 % FCS-RPMI at 37°C for 1 h prior 
to the addition of cells. Cells were added to drained columns 
in a volume of 10 ml, at 108 cells/ml, and incubated at 37°C, 
5 % co2 , for 1 h. Nonadherent cells were collected in the 
effluent fraction of columns rinsed with prewarmed 10 % FCS-
RPMI at a flow rate of 1 drop/second. Nylon wool non-adherent 
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cells were subsequently incubated with sheep red blood cells 
(SRBCs) treated with 2-aminoethyl isothiouronium bromide 
hydrobromide (AET; Sigma Chemical Co., St. Louis, MO) and 
fractionated over ficoll-hypaque gradients. Erythrocyte 
't. (E+) receptor posi ive T cells were collected from the 
erythrocyte cell pellet following lysis of red cells by 
incubation for 1 min in ice cold lysing buffer, consisting of 
150 mM NH4Cl, 10 mM KHC03 and 0.1 mM EDTA. Residual 
contamination by monocytes and granular cells was removed by 
treatment with a lysosomotropic agent, leucine methyl ester 
(LME; Sigma Chemical Co.), at 5 mM for 50 min at 22°C. Purity 
of T cells was confirmed by flow cytometric analysis of HLA-
DR, CD14 and CD2 cell surface marker expression and absence 
of proliferative responses towards either concanavalin A (Con 
A) or anti-CD3 mitogens. 
b. Isolation of T Cell Subpopulations 
Negative selection of CD4+ and CDS+ T cell subsets from 
purified T cells was performed by coating cells with murine 
monoclonal antibodies followed by magnetic bead removal of 
unwanted T cell subsets. Purified T cells were coated with 
saturating amounts of anti-CDS (OKT8) or anti-CD4 (KT69-7) 
antibodies for 30 min on ice and washed three times with ice-
cold HBSS containing 5% FCS. Murine monoclonal antibody 
coated T cells were subsequently incubated with goat-anti-
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mouse conjugated magnetic beads (Advanced Magnetics, Inc., 
Cambridge, MA) for 30 min on ice in a 25 cm2 flask (Corning 
Glass Works, Corning, NY) at a bead:cell ratio of 40:1. Cells 
conjugated to magnetic beads were removed by a 5 min exposure 
of the flasks to two vertical magnetic separators (Advanced 
Magnetics, Inc.). The negatively selected cells were 
collected by pipetting and retreated in an identical fashion 
with fresh magnetic beads. Purity of negatively selected T 
cell subpopulations was confirmed by flow cytometric analysis 
of CD4 and CDS cell surface markers. 
Positive selection of T cell subpopulations was 
achieved by fluorescence activated cell sorting. CD4+ and 
ens• T cell subsets were stained with saturating amounts of 
FITC anti-Leu 3a&b and PE anti-Leu 2a for 30 min on ice, 
washed three times with ice-cold HBSS containing 5% FCS and 
sorted using a FACS 420 (Becton-Dickinson Inc.). Likewise, 
CD45RA+ and CD45RO+ T cell subsets were stained with saturating 
amounts of FITC conjugated anti-Leu lS (IgG1 ) and unconjugated 
UCHLl (IgG28 } plus PE conjugated goat anti-mouse IgG28 , 
followed by cell sorting. Purity of T cell subpopulations was 
confirmed by flow cytometric analysis. 
Anti-CD3 Mitogenesis 
Ant i-CD3 mitogenesis was performed by the addition 
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autologous T cells and anti-CD3 (50 ng/ml) to plates 
containing 48 h preadhered lawns of monocytes, at T 
cell:monocyte ratios of 4:1. T cells were activated in anti-
CD3 mitogenic cultures for 1 - 48 h. For double chamber well 
experiments, T cells and anti-CD3 were added to monocyte lawns 
in the upper chamber of Transwell plates, employing the same 
concentrations and culture conditions described above. 
All cultures were carried out in culture medium 
consisting of 5 % normal human serum-RPM!, supplemented with 
2 mM 1-glutamine and 50 µg/ml gentamycin. Endotoxin levels 
of cultures and components were monitored by the chromogenic 
Limulus Amoebocyte Lysate assay (Whittaker Bioproducts Inc., 
Walkersville, MD) and were below 5 pg/ml. 
For assessments of proliferation, parallel 
microcultures were established in flat-bottomed 96 well 
microtiter plates (Falcon, Becton-Dickinson Labware) using 
105 cells and were incubated for 72 h at 37°C and 5 % co2 • 
Cultures were pulsed with 2 µCi/well [methyl3H]-thymidine 
(6.67 Ci/mrnol, NEN Research Products) for the final 8 h of 
incubation. Cells were harvested onto glass filter strips 
using a PhD cell harvester (Cambridge Technology Inc., 
Cambridge, MA), baked in an ao·c drying oven for 30 min. and 
counted in 3a20 organic scintillation cocktail (Research 
Products International) using an LKB 1219 Rackbeta 
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scintillation counter (LKB Instruments Inc.). 
gon A Mitogenesis 
For assessments of Con A induced proliferations, 105 
cells were incubated at 37°C, 5 % co2 for 72 h in 96 well flat 
bottomed microtiter plates in the presence of 10 µg/ml Con A. 
cell culture and assessments of proliferation were carried 
out as described above. 
Immobilized Anti-CD3 
Anti-CD3 was immobilized by incubation at 100 µg/well 
to flat bottomed 24 well plates (Costar) or at 10 µg/well to 
96 well plates, in buffer consisting of 50 mM Tris, 150 mM 
NaCl, 0.02 % (w/v) NaN3, pH 8.6, for 24 h at 4°C. Prior to 
cell culture, wells were washed four times with HBSS. Cells 
were added immediately at 106 cells/well to 24 well plates or 
105/well to 96 well plates. 
Allogeneic Mixed Lymphocyte Response (MLR) 
Purified responding T cell populations and purified 
allogeneic stimulator monocyte populations were isolated from 
peripheral blood of different normal human donors by the 
procedures described above. For subsequent isolation and 
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analysis of RNA, allogeneic MLRs were established by the 
addition of responding T cells to lawns of stimulator 
monocytes contained in 150 x 20 mm culture plates at T 
cell:monocyte ratios of 2.5:1. T cells were activated in 
allogeneic MLR culture for 12 - 48 h. 
Isolation of RNA 
a. Cell Harvest 
Monocytes and T cells were repurified from anti-CD3 
mitogenesis cultures for subsequent isolation of RNA. 
Monocytes were collected from plates following the removal by 
vigorous washing of non-adherent cells. Adherent cells were 
then detached from culture plates by the addition of ice cold 
ca2•- and Mg2•- free HBSS, containing 2.5 mM EDTA, for 30 min 
followed by gentle scraping with a rubber policeman. 
Contaminating T cells in the adherent fraction of mitogenic 
cultures were depleted by treatment with anti-CD3 plus 
complement (3-4 week rabbit; Pel-Freez, Brown Deer, WI), at 
37°C for 30 min. Purity of the resulting monocytes prior to 
RNA extraction was confirmed by flow cytometric analysis of 
HLA-DR, CD14 and CD2 cell surface marker expression. 
T cells were isolated from the non-adherent cell 
fraction by rosetting with AET treated T cells. Purity of 
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resultant E+ T cells was confirmed prior to RNA extraction by 
flow cytometric analysis of HLA-DR, CD14 and CD2 cell surface 
marker expression. 
At the time of harvest, all culture supernates were 
collected, centrifuged and stored frozen at -2o·c for 
subsequent assays of secreted cytokine levels. 
b. RNA Extraction 
Total cellular RNA was isolated by centrifugation of 
guanidinium isothiocyanate cell lysates over a cesium chloride 
cushion (127). Cells were washed once with ice cold HBSS 
prior to RNA extraction and were > 80 % viable, as judged by 
trypan blue dye exclusion. Cells were lysed by the addition 
of 2.5 ml lysis buffer, consisting of 4 M guanidinium 
isothiocyanate (BRL Life Technologies Inc.), 0.5 % Sarkosyl, 
25 mM sodium citrate and 0.1 M P-2-mercaptoethanol. DNA was 
sheared by passing the cell lysate four times through a 19 
gauge needle. Cell lysates were made 2.4 M with respect to 
CsC12 by the addition of 1 g CsC12 and loaded onto 1.2 ml 
cushions composed of 5.7 M csc12 and 0.1 M EDTA in SW40.l Ti 
ultraclear ultracentrifuge tubes (Beckman Instruments Inc., 
Palo Alto, CA). RNA was pelleted through the CsC12 cushion by 
centrifugation in an SW40.1 Ti rotor (Beckman Instruments) at 
225,000 x g for 16 h, at 2o·c. Following centrifugation, the 
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guanidinium isothiocyanate layer, containing protein and 
sheared DNA, was carefully removed and the sides of the tubes 
cleaned with a sterile cotton-tipped applicator before 
inversion to remove the CsC12 layer. Tubes were cut below the 
level of the CsC12 interface and RNA pellets resuspended by 
repeated pipetting (> 50 times) in 0.15 ml diethyl 
pyrocarbonate treated water (DEPC-H20). RNA yields were 
quantitated by absorbance at 260 nm and purities confirmed by 
A260m!A280nm ratios, which were > 1. so in all experiments. 
Slot Blot and Northern Blot Hybridization 
a. Immobilization of RNA 
RNA was denatured for slot-blot analysis by heating at 
65°C 1 in the presence of 8 % formaldehyde, 6 X SSC (1 X SSC 
= 0.15 M NaCl, and 0.3 M sodium citrate; pH 7.2), followed by 
quenching on ice for 10 min. The RNA was applied under vacuum 
to nitrocellulose membranes (BRL Life Technologies Inc.) 
employing a "Hybrislot" manifold (BRL Life Technologies Inc.) 
at 2.5, 0.5 and 0.1 µg RNA per well. For northern blot 
analysis, RNA (10 µg) was denatured by heating at 50°C for 1 
h in the presence of 1 M glyoxal I 50 % (v/ v> dimethyl 
sulfoxide, and 10 mM phosphate buffer (pH 6.8) followed by 
quenching on ice for 10 min. RNA was fractionated by size in 
the presence of 0.1 % bromophenol blue by electrophoresis in 
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1 .4 % agarose (FMC Bioproducts) gels. Gels were made up in 
running buffer, consisting of 10 mM phosphate buffer (pH 6.8). 
RNA was transferred to Gene Screen Plus membranes (NEN 
Research Products) by capillary blotting in 10 X SSC transfer 
buffer for 18 h and membranes were air dried. 
b. Hybridization 
Membranes were prehybridized by heating at 42°C for 24 
h in prehybridization buffer, consisting of 50 % deionized 
formamide 1 10 % dextran sulfate, 1 % SDS, 5 X SSPE (1 X SSPE 
= 0.15 M NaCl, 10 mM NaH2P04 , and 1 mM EDTA; pH 7.2), 5 X 
Denhardt's solution (1 X Denhardt's = 0.02 % (w/v) ficoll, 
0. 02 % (w/ v> polyvinylpyrrolidone, and 0. 02 % (w/ v> BSA) and 
250 mg/ml freshly denatured salmon sperm DNA. Hybridization 
was carried out for 24 hat 42°C following the addition of 106 
CPM/ml 32P-labelled cDNA, which was heated at 1oo·c for 10 min 
and quenched on ice for 5 min prior to addition to 
prehybridized membranes. 
Following hybridization, nitrocellulose and Gene screen 
Plus membranes were subjected to two 30 min low stringency 
washes, performed with 2 X SSPE, and 0.4 % SDS at 22·c. 
Subsequently, membranes were subjected to two 30 min high 
stringency washes, performed for nitrocellulose membranes with 
0.1 X SSPE and for Gene Screen Plus membranes with 0.1 X SSPE, 
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and o. 4 % SDS. High stringency washes on both types of 
membrane were carried out at 56 ·c for IL-1 a and IL-6 
hybridizations and at 60°C for IL-1 p and H3.3 hybridizations. 
Autoradiography was performed at -85°C in the presence of X-
ray film (Kodak XAR-5, Eastman Kodak Company, Rochester, NY) 
and two intensifying screens (Lightning Plus, NEN Research 
Products) for the lengths of time indicated in appropriate 
figure legends. 
c. Rehybridization 
Rehybridization was accomplished by stripping 
radiolabelled cDNAs from nitrocellulose by boiling in T.E. 
(pH 8.0) for 10 min, followed by baking of membranes at 80°C 
for 2 h. Gene Screen Plus membranes were stripped for 
rehybridization by boiling in T.E. (8.0), 1 % SDS for 1 h. 
Membranes were sequentially hybridized with radiolabelled cDNA 
probes corresponding to the human IL-1 a, IL-1 p and IL-6 
genes and the constitutively expressed mouse histone variant 
H3.3 gene. 
d. Data Analysis 
Autoradiograms were scanned with an LKB Ultroscan XL 
Laser Densitometer (LKB Instruments Inc., Gaithersburg, MD). 
Hybridization signal intensities were calculated 
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by 
integration of the densitometric curves and were expressed as 
the area under a curve in units of A/mm2 • 
To correct for differences in the amounts of RNA bound 
to membranes and enable quantitative comparisons of IL-1 mRNA 
expression among samples, data were expressed as an IL-1 mRNA 
index. The IL-1 mRNA index is represented by the formula: 
IL-1 mRNA index = AIL_,/AH3.3 
The IL-1 mRNA index was calculated as the ratio of the 
hybridization signal intensity obtained with cDNA probes for 
IL-1 a or IL-1 (3 (An_ 1) to the signal intensity obtained for 
the same sample using a cDNA for the constitutive hi stone 
variant HJ. 3 (AH3.3 ), whose stable mRNA levels have been shown 
to be independent of the state of differentiation of cells 
(128) and remain unaffected by changes in cytoskeletal 
architecture that may accompany the activation of monocytes 
( 118) • To allow quantitative comparisons of IL-1 mRNA 
induction by given stimuli among multiple experiments, each 
IL-1 species was expressed as a percent IL-1 mRNA index 
relative to the maximum (100 %) LPS inducible response. 
Paraform.aldehyde Fixation of T Cells 
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Prior to fixation, purified T cells were washed twice 
with HBSS to remove residual serum. Cells were resuspended 
in 50 ml polypropylene centrifuge tubes (Falcon, Becton-
oickinson Labware) at a final concentration of 5 x 106 
cells/ml in HBSS. An equal volume of prewarmed, sterile 1 % 
(w/v) paraforrnaldehyde (Sigma Chemical Company) was added and 
the mixture incubated with shaking at 37°C for 5 min. 
Paraforrnaldehyde was prepared as a stock 5 % solution in HBSS 
(pH 7 .2) by heating at 65°C for 1 h, followed by sterile 
filtration through a 0.22 µ filter (Nunc). Stock 
paraformaldehyde was stored at 4°C and was diluted freshly on 
the day of fixation in HBSS. Fixation was terminated by the 
addition of 10 volumes of ice-cold 0.06 % glycylglycine (Sigma 
Chemical Company) in HBSS (pH 7.2) followed by centrifugation. 
Fixed cells were washed an additional two times with ice-cold 
HBSS and two times with ice-cold HBSS containing 5 % FCS. 
Fixed cells were incubated at 37°C overnight in 10%-RPMI to 
leach any remaining paraformaldehyde. 
Completeness of fixation and maintenance of cell 
surface integrity following fixation were confirmed by flow 
cytometric analysis of propidium iodide (PI; Sigma Chemical 
Co.) vital dye exclusion (124) as well as CD3 and CDS cell 
surface marker expression. 
Inhibition of Protein synthesis 
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T cells were incubated with o - 40 µg/ml emetine (Sigma 
chemical Company), an inhibitor of de .D.QY.Q protein synthesis, 
at 5 x 106 cells/ml in 10 % FCS-RPMI for 2 h at 37°C. 
Following emetine treatment, T cells were washed three times 
in HBSS containing 5 % FCS, incubated for 1 h at 37°C in 10 
% FCS-RPMI and washed an additional two times with HBSS 
containing 5 % FCS. 
Inhibition of protein synthesis was monitored by 
assessing 3H-leucine incorporation into T cells, following a 
48 h stimulation with immobilized anti-CD3 and 50 U/ml rIL-2 
(Cetus Corporation, Emeryville, CA). 3H-leucine incorporation 
was performed using 106 T cells collected from each treatment 
group. Cells were washed twice in leucine-free RPMI to remove 
cold leucine and incubated for 2 h at 37°C in leucine free 10 
% FCS-RPMI, containing 25 µCi 1-[3, 4, 5-3H(N)] leucine (153.0 
Ci/mmol, NEN Research Products). Cells were washed four times 
with HBSS containing 5% FCS to remove unincorporated 3H-
leucine and protein was precipitated from cell pellets by the 
addition of 50 µl 0.5 % Triton X-100 {Sigma Chemical Company), 
50 µl FCS and 1 ml 15 % trichloracetic acid {TCA}. Protein 
precipitates were formed by incubation for 1 h on ice. 
Precipitates were washed five times with 15 % TCA to remove 
unincorporated 3H leucine and counted in aqueous scintillation 
cocktail (Ready-Sol, Beckman Instruments Inc.) using an LKB 
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Rackbeta 1219 scintillation counter (LKB Instruments Inc.). 
Assay of secreted Cytokines 
Secreted cytokine levels in culture supernates were 
determined using commercially available specific enzyme linked 
immunoassays for IL-1 a (Endogen Inc., Boston, MA) and IL-1 
~ (Cistron Biotechnology, Pine Brook, NJ) or specific 
radioimmunoassays for IL-2, IFN-¥ and TNF-a (Medgenix Corp., 
Ventrex Laboratories, Inc., Portland, ME). 
LBRM-33-lAS conversion Bioassay for Secreted IL-1 Activity 
Biologic IL-1 activity was assayed by the LBRM-33-lAS 
conversion bioassay, as previously described (125). LBRM-33-
1A5 cells ( 5 x 104 ), contained in volume of 100 µl, were 
cultured with 100 µl IL-1 containing supernates for 24 h at 
37°C and 5 % co2 in triplicate wells of round bottomed 96 well 
plates (Falcon, Becton-Dickinson Labware) in the presence of 
0.01% PHA-P (Wellcome Diagnostics, Dartford, England). 
Supernates (100 µl) were collected from plates after 
centrifugation at 400 x g and assayed for IL-2. Control 
cultures were performed in the absence of PHA to determine 
intrinsic IL-2 levels in test supernates. 
Assays for IL-2 were carried out employing the IL-2 
dependent CTLL2 o. J 1 ine ( 12 6) . 
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CTLL20.J cells (5 x 103), 
contained in a volume of 100 µl, were cultured with 100 µl 
serial dilutions of IL-2 containing supernates for 24 h at 
37°c and 5 % co2 in triplicate wells of round bottomed 96 well 
plates and pulsed with 1 µCi 3H-thymidine (6.67 Ci/mmol, NEN 
Research Products) over the final 8 h of culture. 
Incorporation of 3H-thymidine into cells was determined as 
described previously. IL-1 activities were expressed as IL-
1 units/ml, where 1 unit of activity corresponded to the 
dilution of supernate required for so % maximal proliferation 
relative to a mouse recombinant IL-1 control. 
Flow cytometry and Cell Sorting 
For analysis of cell surface markers by flow cytometry, 
1 x 105 - 1 x 106 cells were stained in 12 x 75 mm polystyrene 
centrifuge tubes (Falcon, Becton Dickinson Labware In.) with 
saturating amounts of fluorochrome conjugated antibody for 30 
min on ice, followed by three washes in ice-cold HBSS 
containing 5 % FCS. Cells were resuspended in 1 ml phenol red 
free HBSS containing 5 % FCS and were analyzed for 
fluorescence using a FACS Analyzer (Becton Dickinson 
Immunocytometry Systems, Mountain View, CA). The noise 
threshhold was set to exclude volume signals below those of 
lymphocytes. All analyses were performed using 
photomultiplier voltages and gain settings that were 
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standardized using fluorescent calibration beads, and all 
signals were processed using logarithmic amplification. 
Fluorochrome conjugated mouse IgG2a monoclonal antibody 
controls were used to allow for the establishment of markers 
for distinguishing positive and negative cell populations. 
Positive staining was defined visually based on natural 
boundaries between positive and negative cell populations. 
cells were sorted using a FACS 420 (Becton Dickinson 
Immunocytometry Systems) equipped with a 2 W argon laser at 
rates of 2000 cells/sec with abort circuitry activated. 
For analysis of PI uptake, fixed T cells were incubated 
in a volume of 0.5 ml on ice for 30 min with 50 µg/ml PI in 
HBSS. Cells were analyzed for uptake of PI using FL2 
photomultiplier voltage settings of 430 v. Unfixed T cells 
were employed as controls to allow for the establishment of 
markers for distinguishing viable and non-viable cell 
populations. 
RESULTS 
composition of Purified Cell Subpopulations 
The composition and purity of monocyte and T cell 
populations employed in these studies was confirmed by flow 
cytometric analysis of cell surface markers and mitogen-
induced proliferative responses. The results of flow 
cytometric determinations of cell surface marker expression 
are presented in Table l. Evaluations of cell purity were 
performed on monocyte and T cell subpopulations isolated from 
peripheral blood mononuclear cells or from in vitro anti-CD3 
mitogenic cultures. Purities of monocyte and T cell 
populations were assessed by expression of the T cell CD2 cell 
surface marker and monocyte specific CD14 and HLA-DR markers 
respectively. 
Monocytes isolated from PBMCs in 27 separate 
experiments (n = 27) were 77.1 ± 1.6 % positive for expression 
of CD14 (CD14+), 85.9 ± 1.2 % HLA-DR+ and 1.9 ± 0.3 % CD2+. T 
cells isolated from PBMCs (n = 7) were 3.3 ± 0.9 % CD14+, 2.4 
± 0.9 % HLA-DR+ and 93.4 ± 0.8 % CD2+. Representative contour 
plots illustrating cell surface marker expression of these 
cell subpopulations are shown in Figure l of the Appendix. 
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Table 1. Cell surface Phenotypes of Cell Populations Purified 
From PBMCs and Anti-CD3 Mitogenic cultures Purity of cell 
subpopulations was evaluated by flow cytometric analysis of 
CD14, HLA-DR and CD2 cell surface marker expression. T cells 
were depleted from the adherent cell fraction of anti-CD3 
mi togenic cul tu res by treatment with anti-CD3 plus rabbit 
complement. Results are presented as mean ± S.E.M. percent 
cells positive for staining with fluorochrome conjugated anti-
CD14 (PE anti-LeuM3), anti-HLA-DR (PE anti-HLA-DR) and anti-
CD2 (FITC anti-Leu5) antibodies, obtained from multiple 
experiments (n) as shown. Representative flow cytometric 
contour plots illustrating cell surface marker expression of 
these cell subpopulations are shown in Figures 1 and 2 of the 
Appendix. 
Cell Surface Phenotypes of Cell Populations Isolated from PBMCs and 
Anti-CD3 Mitogenic Cultures 
% Positive Cells (Mean± S.E.M.) 
# of Expts. 
Cells Source (n) 
Monocytes PBMCs 27 
T Cells PBMCs 7 
Adherent Cells Mitogenic 10 
Culture 
Adherent Cells Mitogenic 10 
Antibody and c· Treated Culture 
T Cells Mitogenic 4 
Culture 
CD14+ HLA-DR+ 
77. 1 ± 1. 6 85.9 ± 1.2 
3.3 ± 0.9 2.4 ± 0.9 
40.8 ± 4.4 54.1 ± 4.7 
76.2 ± 1. 5 82.6 ± 2.2 
3.9 ± 0.2 3.6 ± 0.5 
CD2+ 
1.9 ± 0.3 
93.4 ± 0.8 
16.6 ± 
3.8 ± 
88.9 ± 
2.3 
0.8 
3.4 
U1 
N 
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Monocytes and T cells reisolated from anti-CD3 
mitogenic culture were assessed for purity prior to RNA 
extraction and analysis of mRNA content, as shown in Table 1. 
Monocytes enriched from the adherent fraction of mitogenic 
cultures (n = 10) contained a significant proportion (16.6 ± 
2.3 %) of residual CD2+ T cells and non-viable double negative 
cells. Contaminating T cells in this fraction were 
subsequently depleted by treatment with anti-CD3 plus 
complement. Phenotypic analysis of the final eel 1 population, 
performed in the presence of propidium iodide (PI) in order 
to exclude non-viable cells from analysis, revealed these 
cells to be 76.2 ± 1.5 % CD14+, 82.6 ± 2.2 % HLA-DR+ and 3.8 
T cells, repurified from the non-adherent 
fraction of mitogenic cultures by rosetting with AET treated 
sheep erythrocytes, were 3.9 ± 0.2 % CD14+, 3.6 ± 0.5 % HLA-
DR+ and 88.9 ± 3.4 % CD2+. Representative contour plots 
illustrating the cell surface marker expression of these cell 
subpopulations are shown in Figure 2 of the Appendix. 
These phenotypic data demonstrated that monocyte and 
T cell subpopulations combined for mitogenic activation and 
subsequently reisolated for m.RNA analysis contained < 4 % 
contamination by the reciprocal cell type. 
Purity of T cells isolated from PBMCs was also 
confirmed by assessing their inability to proliferate in 
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response to the monocyte dependent T cell mitogen, 
concanavalin A (Con A). In all experiments, Con A induced 
proliferative responses of isolated T cells, assessed by 3H-
thymidine incorporation, were < 5 % of unseparated PBMCs. 
Representative responses from 10 donors demonstrated 3H-
thymidine incorporation by T cells of 1, 876 ± 441 cpm, 
compared to 88,413 ± 13,790 cpm by PBMC control cultures, or 
a mean percent response of 2.2 ± 0.3 %. These data 
demonstrated that the T cells employed in these studies were 
sufficiently depleted of monocytes that they were unable to 
respond towards the T cell mitogen Con A, thus confirming the 
purity of these cells. 
The proliferative responses of purified and combined 
monocytes and T cells towards anti-CD3 mitogen are shown for 
4 experiments in Table 2. Whereas purified monocytes and T 
cells failed to proliferate in response to anti-CD3 antibody 
(930 ± 141 and 661 ± 148 cpm respectively) , combining 
monocytes and T cells at a ratio of 1:4 completely restored 
proliferative responses compared to control PBMC cultures 
(111,101 ± 6,519 vs. 117,643 ± 15,688 cpm). 
These proliferative data confirmed the purity of 
isolated cell subpopulations and demonstrated that combined 
monocyte and T cell mitogenic cultures generated the necessary 
costimulatory signals to enable T cells to proliferate. These 
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Anti-CD3 Induced Proliferation of Isolated and Combined 
Cell Subpopulations 
Cells 
Monocytes 
T Cells 
Monocytes Plus 
T Cells (1:4) 
PBMCs 
Stimulus 
Anti-CD3 
Anti-CD3 
Anti-CD3 
Anti-CD3 
3H-Thymidine Incorporation 
(Mean CPM ± S.E.M.) 
772 ± 21 
930 ± 141 
589 ± 145 
661 ± 148 
629 ± 103 
111,101 ± 6,519 
761 ± 61 
117,643 ± 15,688 
Table 2. Anti-CD3 Induced Proliferation of Isolated and 
Combined Cell Subpopulations Proliferation of cell 
populations was assessed by 3H-thymidine incorporation into 
cells at 72 h of culture in the presence of either medium or 
50 ng/ml anti-CD3. Counts represent the mean ± S.E.M. cpm 
from four experiments. 
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cell populations were therefore suitable for the study of 
signalling events lead~nq to the production of IL-1 during 
primary immune activation. 
Induction of Monocyte IL-1 a and 8 mRNA Following Adherence 
to Plastic 
Inasmuch as previous studies have demonstrated that IL-
1 mRNA levels were induced in monocytes following adherence 
to plastic, initial experiments were performed to characterize 
the spontaneous expression of IL-1 a and fi mRNAs in monocytes 
following their isolation from peripheral blood and adherence 
to plastic. 
Freshly isolated monocytes were adhered to culture 
plates and evaluated by slot blot hybridization analysis, at 
time points of up to 48 h following adherence, for detection 
of IL-1 a, IL-1 p and histone H3.3 mRNAs, as shown in Figure 
,l. To correct for any differences in the amounts of RNA 
attached to membranes and enable quantitative comparisons of 
IL-1 mRNA expression among samples, the hybridization signals 
obtained with cDNA probes for
1
IL-l a and~ were normalized 
with respect to the signal obtained for the constitutive 
histone HJ.3 gene and were expressed as IL-1 mRNA indices. 
These results, depicted in Figure 2 as IL-1 mRNA indices, 
demonstrated that monocyte IL-1 a and p mRNAs were detectable 
57 
Ti me (h) of adherence 
0 12 24 48 . 
IL-1 f' I 
IL-1 0C. 
' I • 
H3.3 
' 
I 
' 
Figure 1. Slot Blot Analysis Depicting Kinetics of Induction 
of Monocyte IL-1 mRNAs Following Adherence to Plastic Total 
cellular RNA was extracted from monocytes at the designated 
time points following adherence and subjected to slot blot 
analysis as described in Materials and Methods. Membranes 
were sequentially hybridized with llP-labelled cDNAs 
corresponding to the coding regions of human IL-1 ~' human IL-
1 a, and the mouse histone H3.3 genes. Autoradiography was 
carried out with two enhancing screens for 18 h for IL-1 ~' 
40 h for H3.3 and 96 h for IL-1 a. Representative results 
from one of four experiments are shown. 
I 
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Figure 2. Induction of Monocyte IL-1 m.RNAs Following 
Adherence, ouantitated as IL-1 a and S mRNA Indices 
Hybridization signals depicted in Figure 1 were evaluated by 
densitometric scanning of the autoradiogram and quantitated 
as an IL-1 mRNA Index (Materials and Methods), expressed as 
percent maximum IL-1 mRNA Indices for each IL-1 species. 
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immediately prior to adherence (t =oh), achieved maximum 
levels at 12 h following adherence and returned to low or 
undetectable levels by 48 h. 
Inasmuch as previous studies showed that transcription 
of the histone H3.3 gene remained unaffected by cell cycle or 
stage of differentiation of cells, this investigation employed 
H3. 3 as a cons ti tuti ve control gene. To confirm that monocyte 
levels of H3.3 rnRNA remained unaffected following stimulation 
with LPS or during anti-CD3 mitogenesis, the percent change 
of H3. 3 mRNA levels between stimulated and unstimulated 
monocytes was determined. As calculated from 21 different 
experiments, the mean percent change of monocyte H3.3 rnRNA 
levels upon stimulation with LPS was 1.04 ± 3.7 % and with 
anti-CD3 mitogenesis was o. 26 ± 5.1 % • These results 
demonstrated that mean levels of H3.3 mRNA in monocytes were 
not significantly affected by stimulation. 
The results of experiments examining plastic adherence 
induced monocyte IL-1 mRNAs demonstrated that, following an 
initial period of mRNA induction, the expression of IL-1 a and 
~ mRNAs in monocytes returned to undetectable levels by 48 h 
of adherence. Subsequent experiments examining the induction 
of IL-1 mRNA in monocytes during anti-CD3 mitogenesis 
therefore employed resting monocytes which had been cultured 
for 48 h on plastic plates in order to allow spontaneous IL-
60 
1 mRNA levels to subside. 
Monocyte IL-1 er and 8 mRNAs Are Induced During Anti-CD3 
Mitogenesis 
Experiments were carried out to determine whether IL-
1 a and ~ mRNAs were induced in monocytes stimulated by the 
addition of T cells plus anti-CD3. These studies were 
performed according to the experimental scheme depicted in 
Figure 3. Purified, 48 h adherent monocytes were incubated 
with purified autologous T cells plus anti-CD3, using T cell 
to monocyte ratios of 4:1. Total cellular RNA was extracted 
from monocytes at 1 - 48 h time points of anti-CD3 mitogenesis 
and evaluated by northern or slot blot hybridization analysis 
for detection of IL-1 a and ~ mRNAs. Culture supernates were 
collected at 1 - 48 h time points for detection of secreted 
IL-1 and other cytokines generated during anti-CD3 
mitogenesis. 
Representative results from one of two experiments 
examining the induction of monocyte IL-1 mRNA during anti-CD3 
mi togenesis are illustrated in Figure 4. Results demonstrated 
that the predicted 2.3 kb IL-1 a and 1.8 kb IL-1 p mRNAs were 
both induced in monocytes stimulated by the addition of T 
cells plus anti-CD3 (lanes 6-10), but not by the addition of 
T cells or anti-CD3 alone (lanes 13 and 14) . No residual 
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Figure 3. Experimental Scheme Diagram summarizes the 
experimental steps utilized throughout the course of the 
investigation, including the addition of anti-CD3 plus 
purified T cells to lawns of autologous monocytes and the 
methods employed for the subsequent analysis of IL-1 generated 
during anti-CD3 mitogenesis. 
Experjmental Scheme 
T Cells 
Antl-CD3 o 0 o [:~ _uo ~oo .J 
0-48 h 
Remove Adherent Celts 
----~ .... Ce l1 Surf ace 
Phenotyplng 
Extract Total Cellular RNA 
Detection of Speclf le mRNAs 
Cby Northern or Slot Blot Analysis> 
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background IL-1 a: or {3 mRNA expression was detected in 
monocytes cultured in the presence of medium alone (lanes 11-
12). Furthermore, RNA extracted from activated T cells which 
were purified from anti-CD3 mitogenic cultures at 12 h 
contained no detectable IL-1 a: or {3 mRNAs (lane 15). IL-1 a: 
and · {3 mRNAs were both induced in monocytes stimulated in 
control cultures with LPS (lanes 1-5). These results 
demonstrated that IL-1 a: and {3 mRNAs were induced in monocytes 
during anti-CD3 mitogenesis and that induction required the 
presence of both T cells plus anti-CD3. Furthermore, IL-1 
mRNA was induced only in the monocyte population. Finally, 
detection of the expected sizes of mRNA species confirmed the 
specificity of the IL-1 cDNA probes for use in subsequent 
studies. 
The kinetics of appearance of monocyte IL-1 mRNAs during 
anti-CD3 mitogenesis (lanes 6 - 10) revealed that both IL-1 
a: and {3 mRNAs were detectable in monocytes as early as 1 h 
following the addition of T cells plus anti-CD3, reached 
maximum levels at 12 h and declined by 24 h. Similar kinetics 
of IL-1 rnRNA induction were observed in all individuals 
studied (n = 9). In all individuals IL-1 a: and {3 mRNAs were 
detectable at 1 h of anti-CD3 mitogenesis and decreased by 24 
h. In B out of 9 individuals, peak induction of monocyte IL-
1 a: and {3 mRNA occurred at 12 h, whereas in 1 individual it 
occurred at 4 h. These data demonstrated that induction of 
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Cells Mo Mo/T Mo Mo Mo/T 
stimulus LPS antl-CD3 
anti 
-CD3 
Time (h) 1 2 4 12 24 1 2 4 12 24 1 12 12 12 11 
18 s ... 
IL-1 oe-
18 s ... 
IL-1 ~ 
Lane 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Figure 4. Northern Blot Analysis, Depicting Induction of IL-
1 et and 13 mRNAs in Monocytes During Anti-CD3 Mitoqenesis 
Northern blot -analysis was performed using 10 µg total 
cellular RNA extracted from monocytes stimulated with 10 µg/ml 
LPS (lanes 1-5), T cells plus 50 ng/ml anti-C03 (lanes 6-10), 
medium only (lanes 11-12), anti-CD3 only (lane 13) or T cells 
only (lane 14) . RNA was extracted from activated T cells 
repurified from anti-CD3 mitogenic cultures (lane 15). The 
position of the 18 s ribosomal RNA band is designated by an 
arrow. Autoradiography was carried out in the presence of 
two enhancing screens for 96 h (IL-1 a) and 18 h (IL-1 ~). 
Representative results from one of two experiments are shown. 
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monocyte IL-1 a and f3 mRNA during anti-CD3 mitogenesis 
occurred by 1 h and peaked at 12 h following the addition of 
T cells plus anti-CD3. 
comparisons of IL-1 a and IL-1 ~ mRNAs induced during 
anti-CD3 mi togenesis revealed that both exhibited similar 
kinetics of appearance. A comparison of the kinetics of peak 
IL-1 a and IL-1 ~ mRNA induction in 9 experiments, 
demonstrated that peak induction occurred in monocytes at the 
same time point for both IL-1 species in all individuals 
tested, whether stimulated by LPS or anti-CD3. These data 
suggested that induction of IL-1 a and IL-1 f3 were 
coordinately regulated. 
A comparison between maximum levels of IL-1 a and IL-
1 f3 mRNAs induced during anti-CD3 mitogenesis, relative to the 
maximum levels inducible by LPS, revealed that relative IL-1 
a mRNA levels were higher than relative IL-1 f3 mRNA levels in 
7 out of 9 individuals tested. Expressed as a percent of the 
LPS inducible response for that IL-1 species, mean percent IL-
1 mRNA indices during anti-CD3 mitogenesis were 47.2 ± 7.4 % 
for IL-1 a and 35.9 ± 5.7 % for IL-1 f3 (p < 0.05 by paired t 
test analysis). These data demonstrated that IL-1 a mRNA 
levels induced during anti-CD3 mitogenesis, relative to those 
induced by LPS, were greater than IL-1 f3 mRNA levels. 
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In the study group as a whole, quantitative levels of 
IL-l mRNAs induced during anti-CD3 mitogenesis, relative to 
maximum LPS inducible levels, varied among different 
individuals tested. Maximum levels of IL-1 mRNA induced 
during anti-CD3 mitogenesis in 21 different experiments ranged 
between 15.0 and 76.0 % of maximum LPS inducible levels, with 
a mean value of 40.4 ± 9.1 %. These data demonstrated that, 
although qualitative aspects of IL-1 mRNA induction during 
anti-CD3 mitogenesis were comparable among different 
individuals, considerable quantitative differences existed. 
To avoid these quantitative inter-donor variabilities from 
biasing the results of later experiments, all subsequent 
experiments examining induction mechanisms of monocyte IL-1 
mRNA were therefore presented as results from a single 
experiment, representative of the number of experiments noted 
in the text, instead of means from multiple experiments. 
Finally, preliminary studies were carried out to 
determine whether mRNA for IL-6, a costimulatory molecule 
acting in synergy with IL-1 during T cell activation, could 
similarly be induced in monocytes during anti-CD3 mitogenesis. 
The northern blot depicted in Figure 4 was rehybridized to 32P 
labelled IL-6 cDNA for detection of IL-6 mRNA. Results shown 
in Figure s demonstrated that IL-6 specific mRNA, migrating 
at 1.1 kb, was detectable at the 4 and 12 h time points of 
anti-CD3 mi togenesis and obtained maximal levels by 12 h. 
Cells 
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Mo/T Mo 
anti-CD3 
2 4 12 24 1 12 
7 8 9 10 11 12 
Northern Blot Analysis Depicting Induction of 
Monocyte IL-6 mRNA During Anti-CD3 Mitogenesis 10 µg total 
cellular RNA, extracted from monocytes stimulated for the 
designated periods of time with either 10 µg/ml LPS or T cells 
plus 50 ng/ml anti-CD3, was evaluated by northern blot 
analysis for detection of IL-6 mRNA. The position of the 18 
S ribosomal RNA band is designated by an arrow. Auto-
radiography was performed in the presence of two enhancing 
screens for 96 h. Results from a single experiment are shown. 
I 
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similar to IL-1 mRNA, IL-6 mRNA was not detectable in 
monocytes cultured in the presence of medium alone, but was 
detectable at 2-12 h time points in monocytes stimulated with 
LPS, attaining maximal levels at 12 h. These results 
demonstrated that mRNAs encoding two costimulatory molecules, 
IL-1 and IL-6, were both detectable in monocytes stimulated 
during anti-CD3 mitogenesis. 
Induction of IL-1 mRNA in Monocytes by T Cells in the Presence 
of Anti-CD3 or Anti-CDS 
A requirement for T cell activation in the induction 
of monocyte IL-1 mRNA during anti-CD3 mitogenesis was 
investigated by determining the ability of T cells plus anti-
CD5, a non-mitogenic T cell specific antibody of the same 
isotype as anti-CDJ, to induce monocyte IL-1 mRNA. 
In these experiments, monocytes were stimulated by the 
addition of anti-CDJ or anti-CD5 mAbs, either alone or in the 
presence of T cells. Total cellular RNA was extracted at 12 
h from monocytes stimulated under these conditions and was 
evaluated by slot blot hybridization analysis for detection 
of IL-1 a and ~ mRNAs. A representative slot blot depicting 
IL-1 ~ mRNA induction from one of three experiments is shown 
in Figure 6. The IL~l mRNA indices for each IL-1 species, 
relative to the maximum (100%) LPS inducible response, are 
Cells 
Stimulus 
IL-1 (:> 
H3. 3 I 
Mo 
LPS 
• 
Mo 
anti-CD3 
Mo Mo/T 
anti-CD5 · anti-CD3 
I t I 
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Mo/T 
anti-COi 
I t• 
Figure 6. Slot Blot Analysis Depicting the Abilities of Anti-
CD3 and Anti-CDS to Induce T Cell Mediated IL-1 mRNA in 
Monocytes Monocytes, stimulated for 12 h with 50 ng/ml anti-
CD3 or anti-cos, in the presence and absence of T cells, were 
evaluated for IL-1 f3 and histone H3. 3 mRNAs by slot blot 
analysis. Autoradiography was carried out in the presence of 
two enhancing screens for 36 h (IL-1 /3) and 72 h (H3.3). 
Representative results from one of three experiments are 
shown. 
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Figure 7. Comparative Abilities of Anti-CD3 and Anti-CDS to 
Induce Monooyte IL-1 a and 8 mRNAs Monocytes, stimulated 
under the same conditions described in the legend to Figure 
~' were evaluated by slot blot anlaysis for IL-1 mRNA content, 
expressed as percent IL-1 mRNA Indices for each IL-1 species 
relative to maximum (100 %) LPS (10 µg/ml) inducible 
responses. Representative results from one of three 
experiments are shown. 
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shown in Figure 7. In contrast to anti-CD3, anti-CD5 was 
incapable of providing the necessary stimulus for the 
induction of IL-l a or f3 mRNAs in monocytes cultured in the 
presence of autologous T cells. In control cultures, neither 
antibody alone induced IL-1 mRNAs when added to monocytes. 
Inasmuch as the cell surface density of the CD5 
molecule was determined by flow cytometric analysis at 
saturating concentrations of antibodies to be 3.3 fold less 
than CD3, additional experiments were carried out to determine 
whether the inability of anti-CD5 to induce monocyte IL-1 mRNA 
was due to the lower levels of anti-CDS binding to T cells. 
In two independent experiments, monocytes stimulated by T 
cells plus fivefold greater concentrations of anti-CDS (250 
ng/ml) failed to exhibit IL-1 a and f3 mRNA induction. 
These experiments demonstrated that induction of IL-1 
a and f3 mRNAs during anti-CD3 mitogenesis involved a T cell 
activation event and was not solely a result of binding of 
antibody/T cell complexes to monocyte Fe receptors. 
Secretion of IL-1 During Anti-CD3 Mitoqenesis 
Supernates from anti-CD3 mitogenic cultures were 
evaluated to assess whether the induction of IL-1 at the mRNA 
level was accompanied by the secretion of IL-1 a and IL-1 f3 
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activities. 
In these experiments, supernates collected at various 
time points from anti-CD3 mitogenic cultures were analyzed for 
secreted IL-1 a and {3 activities serologically, using specific 
immunoassays, and biologically, using the LBRM-33-1A5 
conversion assay. Secreted IL-1 {3 (sIL-1 {3) was detected in 
anti-CD3 mitogenic supernates, using an IL-1 {3 specific enzyme 
linked immunoassay, as early as 4 h of culture and increased 
throughout the 48 h of study, as depicted in Figure 8 for 
representative results from one of 4 experiments. Secreted 
IL-1 a activity was not detected in anti-CD3 mitogenic culture 
supernates in four separate experiments (0 ± o pg/ml) using 
an IL-1 a specific enzyme linked immunoassay which was 
sensitive to 10 pg/ml of IL-1 a. 
Of interest was the observation that mean levels of 
secreted IL-1 {3 induced during anti-CD3 mitogenesis (225 ± 
35. 8) were equal to or greater than those induced by LPS 
(184.2 ± 36.9) in the 16 individuals tested, despite the fact 
that monocyte IL-1 {3 mRNA levels induced by LPS were, in all 
experiments, greater than those stimulated by T cells plus 
anti-CD3. 
Biological 
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Kinetics of IL-1 8 Secretion by Monocytes 
stimulated with LPS or T Cells Plus Anti-CD3 Culture 
supernates, collected at the time points indicated from 
monocytes cultured in the presence of 10 µg/ml LPS or T cell 
plus 50 ng/ml anti-CD3, were evaluated for sIL-1 p activities 
using an IL-1 p specific ELISA. Representative results from 
one of four experiments are shown. N.D. = Not determined. 
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Induction of Secreted Il-1 Activity During 
Anti-CD3 Mitogenesis 
IL-1 Activity (U/ml) 
cells 
Monocytes 
Monocytes 
Plus T Cells 
Stimulus 
LPS 
Anti-CD3 
Time(h) 
24 
48 
12 
24 
48 
Expt.l Expt.2 
26.7 N.D. 
51. 2 32.0 
5.3 N.D. 
6.7 0 
72.0 64.0 
Table 3. Induction of secreted IL-1 Activity During Anti-CDJ 
Mitogenesis Monocytes were cultured in the presence of 10 
µg/ml LPS or T cells plus 50 ng/ml anti-CD3 for the designated 
periods of time and supernates were analyzed for biological 
IL-1 activity by the LBRM-33-1A5 conversion assay. IL-1 
activities were expressed as U/ml, where 1 unit of activity 
corresponded to the dilution of supernate required for half 
maximal responses relative to a recombinant IL-1 control. 
Results from two experiments are shown. N.D. = Not 
determined. 
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confirmed the results obtained by IL-1 J3 specific immunoassay 
by demonstrating that IL-1 activity was detectable at the 
earliest time point tested (12 h) and increased throughout the 
48 h of study. 
These results demonstrated that induction of IL-1 mRNA 
during anti-CDJ mitogenesis was accompanied by the secretion 
of biologically active IL-1 J3, but not IL-1 a. Furthermore, 
peak levels of secreted IL-1 J3 were attained later than peak 
levels of mRNA induction(~ 48 h versus~ 12 h). 
Induction of Monocyte IL-1 Synthesis During Primary Allogeneic 
Mixed Lymphocyte Responses (MLR) 
To confirm the biologic significance of monocyte IL-1 
induction during anti-CDJ mitogenesis, subsequent experiments 
evaluated the induction of monocyte IL-1 during a primary MLR. 
Monocytes were stimulated by the addition of allogeneic 
T cells and evaluated at the designated time points by slot 
blot analysis for induction of IL-1 a and J3 mRNAs. Culture 
supernates were collected for analysis of secreted IL-1 p. 
Induction of IL-1 was evaluated at the mRNA level by slot blot 
analysis, expressed as percent IL-1 mRNA indices for each IL-
1 species relative to the maximum (100 %) LPS inducible 
response, and at the secreted level by IL-1 J3 specific 
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Table 4. Induction of IL-1 During a Primary Mixed Lymphocyte 
Response (MLR) Monocytes were stimulated for the designated 
periods of time by the addition of autologous T cells alone 
(at a 4:1 T cell:monocyte ratio), allogeneic T cells alone, 
or T cells plus 50 ng/ml anti-CD3. IL-1 mRNA content of 
monocytes was evaluated by slot blot analysis and expressed 
as percent IL-1 mRNA indices of each IL-1 species relative to 
maximum (100 %) LPS (10 µg/ml) responses. Levels of sIL-1 ~ 
in culture supernates were quantitated by IL-1 ~ specific 
ELISA sensitive to 20 pg/ml. Results of a single experiment 
are shown. 
Induction of IL-1 During a Primary Mixed Lymphocyte Response (MLR) 
Monocytes Stimulated with: Time (h) 
Autologous T Cells 12 
24 
48 
Allogeneic T Cells 12 
24 
48 
Autologous T Cells 12 
Plus Anti-CD3 
24 
48 
IL-1 rnRNA Index 
(% of LPS Response) 
IL-la: IL-1~ 
0 0 
0 0 
0 0 
12.8 1. 7 
12.8 4.1 
6.4 4.1 
29.8 47.9 
N.D. N.D. 
N.D. N.D. 
sIL-1~ 
(pg/rnL) 
<20 
<20 
<20 
<20 
<20 
195 
36 
185 
390 
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immunoassay (Table 4). Results of a 'single experiment 
demonstrated that both IL-1 a and /.3 mRNAs were induced in 
monocytes following the addition of allogeneic, but not 
autologous, T cells. Whereas IL-1 mRNAs were detected in 
monocytes at 12, 24 and 48 h time points, secretion of IL-1 
1.3 was detected only at the 48 h time point. As a positive 
control, monocytes stimulated by autologous T cells plus anti-
CD3 expressed detectable levels of IL-1 a and f.3 mRNAs and 
secreted IL-1 /.3 activity at all time points tested. 
These results demonstrated that IL-1 was induced at the 
mRNA and secreted levels in monocytes stimulated during a 
primary MLR. These results confirmed the previously observed 
induction of monocyte IL-1, mediated by T cells activated with 
anti-CD3, in an antibody independent model of primary immune 
activation, mediated by T cells triggered through their T cell 
receptors. 
Requirement for Cell contact for Optimal Induction of IL-1 
mRNA During Anti-CD3 Mitogenesis 
The rapid induction of IL-1 mRNA during anti-CD3 
mitogenesis (S 1 h), was consistent with a model requiring 
direct cell contact between T cells and monocytes for 
induction of monocyte IL-1. A requirement for cell contact 
between monocytes and T cells in IL-1 mRNA induction was 
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investigated using double chamber culture wells, as diagram.med 
in figure 9._ These studies employed double chamber culture 
plates, in which the upper and lower compartments were 
separated by a nitrocellulose membrane (0.2 µpore size). 
This membrane was freely permeable to soluble factors 
generated during cell culture, but prevented physical contact 
between cells contained in either chamber. 
In these experiments, adherent monocyte lawns were 
established in both the upper and lower chambers of double 
chamber wells. T cells plus anti-CDJ mAb were added to upper 
chamber monocytes only. Total cellular RNA was extracted at 
various time points from monocytes in both chambers separately 
and was evaluated by slot blot analysis for induction of IL-
1 mRNAs. Consequently, upper chamber monocytes received both 
cell contact mediated and soluble IL-1 inductive signals, 
whereas lower chamber monocytes were exposed only to the 
soluble cytokines generated during the productive anti-CDJ 
mitogenesis in the upper chamber. 
Representative results from one of two experiments 
investigating the induction of IL-1 mRNA in monocytes cultured 
in double chamber wells are shown in Figures 10 and 11. 
Results were presented as percent IL-1 mRNA indices for each 
IL-1 species, relative to the maximum (100 %) LPS inducible 
response. Upper chamber monocytes exhibited a rapid and 
Costar Transwell C24 mm d1amJ 
ant1-CD3 
Permeable membrane 
80 
Upper chamber 
Lower chamber 
Figure 9. Schematic Drawing Depicting Double Chamber Wells 
used to Characterize Cell contact Requirement of 'l' Cell 
Mediated Honocyte IL-1 mRNA Induction Lawns of adherent 
monocytes were established in the upper and lower chambers of 
Costar 24 mm Transwells, in which compartments were separated 
by a nitrocellulose membrane (pore size 0.2 µ) freely 
permeable to soluble factors generated during cell culture but 
which prevented physical contact between cells contained in 
either chamber. The IL-1 mRNA content of monocytes from both 
upper and lower chambers was analyzed at various time points 
following the addition of T cells plus anti-CD3 to upper 
chamber monocytes. 
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pronounced IL-1 mRNA induction, characteristic of that 
previously observed during anti-CD3 mitogenesis (see Figure 
!)· IL-1 a and P mRNAs were both readily detectable at 2 h 
in upper chamber monocytes and attained maximal levels at 12 
h. In contrast, lower chamber monocytes exhibited no 
detectable IL-1 a and p mRNAs at 2 and 4 h time points but did 
exhibit low levels of IL-1 mRNAs at later (2: 12 h) time 
points. 
No differences between the kinetics of IL-1 a versus 
IL-1 P rnRNA induction were observed in lower chamber 
monocytes. The low level of IL-1 a mRNA detectable at 2 h in 
lower chamber monocytes was not evident at the subsequent 4 
h time point and, in two separate experiments, could not be 
repeated (IL-1 a mRNA index: o ± o % of LPS inducible 
response). In control cultures, consisting of lower chamber 
monocytes stimulated by anti-CD3 mAb alone, no IL-1 mRNAs were 
detected, thereby indicating that the low levels of IL-1 
induction observed in lower chamber monocytes were not due to 
a residual T cell contamination. In positive control, 
composed of monocytes stimulated with LPS, the kinetics of 
induction of IL-1 a and p mRNAs were similar to those 
previously observed. 
These results demonstrated that the optimal induction 
of IL-1 mRNA during anti-CD3 mitogenesis occurred in the 
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Figure 10. Induction of IL-1 a mRNA in Monocytes Cultured in 
in Double Chamber Wells Cells were cultured in separate 
chambers of Transwell plates according to the protocol shown. 
Total cellular RNA was extracted from the monocyte population 
designated by the asterisk (*} and subjected to slot blot 
analysis for detection of IL-1 a mRNA. Control cultures 
included monocytes plus medium only, monocytes plus 10 µg/ml 
LPS, or monocytes plus 50 ng/ml anti-CD3 only. Representative 
results from one of two experiments are shown, expressed as 
a percent IL-1 a mRNA Index relative to the maximum (100 %) 
LPS inducible response. 
100 
90 
'E ao 
::;, 
x E 70 
~x 
!: .;: 60 
;i ~ 50 
a:. ..J 
E 'O 40 
lie 
..... 30 
20 
10 
83 
I L-1 ~ 
Time Ch) .2 4 12 24 2 4 1 2 24 2 4 12 24 2 4 12 24 2 4 12 24 
Upper 
Chamber 
Lower 
Chamber 
Stimulus 
Mo* Mo* 
LPS 
Mo*/T Mo/T 
Mo* Mo Mo* 
ant1-CD3 ant1-CD3 ant1-CD3 
Figure 11. Induction of IL-1 § mRNA in Monocytes Cultured in 
in Double Chamber Wells. Cells were cultured and analyzed 
according to the legend to Figure 10 and results were 
expressed as a percent IL-1 f3 mRNA Index relative to the 
maximum (100 %) LPS (10 µg/ml) inducible response. 
Representative results from one of two experiments are shown. 
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presence of cell contact between monocytes and T cells. A 
later phase of low level induction of IL-1 mRNA occurred as 
a result of soluble signals generated during anti-CD3 
mitogenesis. 
~ixed T Cells are capable of Mediating IL-1 mRNA Induction in 
Monocytes: Requirement for Activation of T Cells Prior to 
Fixation 
In order to establish whether both cell contact and 
soluble factors were required for the induction of monocyte 
IL-1 mRNA, experiments were performed to determine whether 
metabolically inactivated T cells, incapable of generating 
soluble factors, retained their ability to induce IL-1 mRNA 
via direct cell contact with monocytes. 
In these experiments, T cells were metabolically 
inactivated by fixation with paraformaldehyde and evaluated 
for their ability to induce monocyte IL-1 mRNA. Three groups 
of fixed T cells were evaluated in these experiments for their 
IL-1 inducing abilities: 
Group 1: Unstimulated T cells. 
Group 2: T cells activated with immobilized anti-CD3. 
Group 3: T cells activated with monocytes plus anti_.CD3. 
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Table s. Confirmation of T Cell Activation Prior to Fixation 
The proliferative responses of T cells employed in the 
fixation studies depicted in Figure 12 are shown, following 
activation by medium (Group 1), immobilized anti-C03 (Group 
2) or monocytes plus 50 ng/ml anti-CD3 (Group 3) . The 
incorporation of 3H-thymidine into cells was assessed at 72 h 
of culture. Control cultures included T cells stimulated with 
anti-C03 alone and T cells stimulated with immobilized anti-
C03 in the presence of 50 U/ml rIL-2. Counts represent mean 
± S.D. cpm from triplicate culture wells an are shown for two 
representative experiments. 
Group 
1 
2 
3 
Confirmation of T Cell Activation Prior to Fixation 
Cells 
T Cells 
T Cells 
Monocytes 
plus T Cells 
T Cells 
T Cells 
Stimulus 
Immobilized 
Anti-CD3 
Anti-CD3 
Anti-CD3 
Immobilized 
Anti-CD3 
+rIL-2 
3H-Thymidine Incorporation (CPM) 
(Mean ± s. E. M. ) 
Expt.1 Expt.2 
298 ± 44 570 ± 27 
5,705 ± 726 3,107 ± 469 
117,127 ± 1,617 74,845 ± 10,579 
432 ± 97 798 ± 27 
122,127 ± 5,149 63,159 ± 5,794 
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Monocytes were stimulated with fixed T cells in the 
presence of anti-CD3 and evaluated for IL-1 a and f3 mRNA 
content. Prior to use in IL-1 mRNA induction studies, fixed 
T cells from each group were evaluated for effectiveness of 
activation and completeness of fixation. 
Activation of T cells was confirmed by proliferative 
responses, as shown in Table s for representative 3H-thymidine 
incorporation data obtained in two of three experiments. T 
cells activated by monocytes plus anti-CD3 (group 3) exhibited 
3H-thymidine incorporations in two experiments of 117,127 and 
74,845 cpm, whereas T cells activated by immobilized anti-CD3 
(group 2) exhibited counts of 5,705 and 3,107 cpm, and 
unstimulated T cells (group 1) demonstrated counts of 298 and 
570 cpm. T cells activated by immobilized anti-CD3 plus 
exogenously added rIL-2, exhibited completely restored 
proliferative responses of 122,127 and 63,159 cpm. These data 
demonstrated that activation of T cells by immobilized anti-
CD3 alone led to the expression of IL-2 receptors without 
leading to proliferation. In control cultures, T cell purity 
was also confirmed by the absence of proliferation in response 
to anti-CD3, a monocyte dependent T cell mitogen (432 and 798 
cpm) . 
Following fixation in paraformaldehyde, T cells were 
evaluated by flow cytometric analysis for integrity of cell 
SS 
Table 6. Effects of Paraformaldehyde Fixation on Cell surface 
Marker Expression and Viability Fluorescent staining with PI, 
anti-CD3 (FITC anti-Leu 4) and anti-CDS (PE anti-Leu 2b) 
antibodies are presented for fixed T cells from each of the 
three activation groups described in the legend to Table 5. 
Results are presented as percent cells positive for staining 
with PI and each of the anti-CD3 and anti-CDS antibodies, as 
shown for two representative experiments. Representative two 
dimensional histograms illustrating these summarized 
phenotypic data are shown in Figures 3 and 4 of the Appendix. 
Effect of Paraformaldehyde Fixation on Cell Surface Marker Expression and Viability 
% Positive Cells 
T Cells 
CD3+ CDS+ PI Uptake 
Stimulus Fixation Expt.1 Expt.2 Expt.1 Expt.2 Expt.1 Expt.2 
Media 84.1 68.7 37.5 32.8 5.2 16.0 
Media + 76.8 67.7 40.4 27.4 98.9 98.3 
Immobilized + 82.4 71. 6 46.0 34.8 98.4 98.8 
Anti-CD3 
Monocytes plus + 78.3 70.0 36.9 30.4 98.9 99.0 
Anti-CD3 
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surface molecules and completeness of fixation, as summarized 
in Table 6. In two separate experiments, fixed T cells from 
all three groups demonstrated complete loss of viability (~ 
98 % PI uptake). Furthermore, fixed T cells demonstrated no 
changes in the binding of f luorochrome conjugated antibodies 
to CD3 and CDS cell surface markers, indicating that these 
cell surface molecules remained intact. Representative 
contour plots illustrating the data summarized in Table 6 are 
shown in Figures 3 and 4 of the Appendix. These data 
demonstrated that fixation of T cells was complete and 
maintained the integrity of functional cell surface molecules. 
Representative results from one of three experiments 
investigating the ability of fixed T cells to induce IL-1 mRNA 
are depicted in Figure 12. Data confirming the activation 
and fixation of T cells employed in this experiment are shown 
in Tables 5 and 6 under Expt. 1. Monocytes were cultured with 
fixed T cells in the presence of anti-CD3 and were evaluated 
by slot blot analysis for induction of IL-1 a and P mRNAs, 
expressed as the percent IL-1 mRNA index for each IL-1 species 
relative to the maximum (100 %) levels achieved by the anti-
CD3 mi togenesis response. The data depicted in Figure 12 
demonstrated that fixed T cells, activated either by 
immobilized anti-CD3 (Group 2) or monocytes plus anti-CD3 
(Group 3) and subsequently fixed, induced monocyte IL-1 a and 
P mRNAs to levels comparable to unfixed T cells. In contrast, 
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Figure 12. Induction of IL-1 mRNA in Monocytes by Fixed T 
Cells: Requirement for Activation of T Cells Prior to 
Fixation. T cells, activated and fixed as indicated, were 
evaluated for their ability to induce monocyte IL-1 a and ~ 
mRNA at 12 h. Results were expressed as percent IL-1 mRNA 
Indices for each IL-1 species relative to maximum (100 %) 
responses induced during anti-CD3 mi togenesis. Representative 
results from one of three experiments are shown. 
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:tb:ed unstimulated T cells (group 1) did not induce IL-1 
tnRNAs. 
These data demonstrated that metabolically inactivated 
'l' cells were fully capable of inducing IL-1 mRNAs in 
JtlOnocytes, but only after activation of these cells. 
~ctivation of T cells by immobilized anti-CD3, which led to 
IL-2 receptor expression but not to proliferation, was 
sufficient to trigger transduction of this cell contact 
roediated IL-1 mRNA signal from T cells to monocytes. 
~ Cell Metabolic Activity Is Required for Induction of IL-1 
§ Secretion by Monocytes 
Inasmuch as metabolically inactivated T cells were 
capable of inducing monocyte IL-1 mRNAs, subsequent 
experiments were carried out to determine whether metabolic 
activity by T cells was required to induce secretion of IL-1 
f3 by monocytes. 
T cells from the three fixation groups were compared 
with unfixed T cells for their ability to induce secretion of 
IL-1 ~ by monocytes in the presence of anti-CD3, as shown in 
Table 7. Representative results from two of three experiments 
demonstrated that, in contrast to unfixed T cells, fixed T 
cells from any of the three fixation groups were incapable of 
Effect of Fixation on T Cell Mediated Induction 
of Monocyte IL-lP Secretion 
Monocytes Stimulated with: sIL-1 p (pg/ml) 
cells Fixation Group Stimulus Expt.1 Expt.2 
T Cells <20 <20 
LPS 330 315 
T Cells anti-CD3 265 340 
T Cells 1 anti-CD3 <20 <20 
T Cells 2 anti-CD3 <20 <20 
T Cells 3 anti-CD3 <20 <20 
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Table 7. Effect of Fixation on T Cell Mediated Induction of 
IL-1 8 Secretion by Monocytes. T cells from the fixation 
groups indicated were evaluated for their ability to induce 
IL-1 p secretion by monocytes in the presence of anti-CD3. 
Supernates, collected at 48 h of culture, were assayed for 
secreted IL-1 p levels using an IL-1 p specific ELISA and 
levels were expressed in pg/ml. Representative results from 
two of three experiments are shown. 
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inducing detectable levels of secreted IL-1 ~ by monocytes. 
These results demonstrated that fixed preactivated T 
cells were incapable of inducing IL-1 p secretion by monocytes 
in the presence of anti-CD3, despite their ability to induce 
IL-1 p mRNA levels in monocytes. Furthermore, these results 
demonstrated that metabolic activity by T cells was required 
for secretion of IL-1 p by monocytes during anti-CD3 
mitogenesis. 
T Cell Transduction of Monocyte IL-1 mRNA Inductive Signals 
Does Not Require Protein synthesis 
To determine whether acquisition of IL-1 mRNA inductive 
capacities by activated T cells required protein synthesis, 
T cells were treated with a protein synthesis inhibitor and 
evaluated for their IL-1 inductive abilities. 
T cells pretreated with emetine, an inhibitor of de 
IlQY.Q protein synthesis, were evaluated for their ability to 
induce monocyte IL-1 mRNA after extensive washing to remove 
traces of emetine. Inhibition of de novo protein synthesis 
in emetine treated T cells was confirmed by monitoring the 
incorporation of 3H-leucine into cells following a 48 h 
stimulation in the presence of solid-phase anti-CD3 and rIL-
2, as shown in Table 8. These data demonstrated that 
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Incorporation of 3H-Leucine by Emetine Treated T Cells 
Emetine 
(µg/ml) 
0 
10 
20 
40 
3H-Leucine Incorporation 
(CPM x 103 ) 
Expt.1 Expt.2 Expt.3 
2,745 980 3,072 
154 41 216 
143 37 164 
85 31 155 
% Inhibition 
{Mean ± S. E.M.) 
94.4 ± 0.8 
95.3 ± 0.5 
96.2 ± 0.6 
Table a. Incorporation of 11-Leucine by Emetine Treated T 
Cells Incorporation of 3H-leucine into T cells are shown 
following a 24 h stimulation in the presence of immobilized 
anti-CD3 and 50 U/ml recombinant IL-2. Results of three 
representative experiments are shown. 
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inhibition of 3H-leucine incorporation by emetine treatment 
ranged between 94.4 ± 0.8 % and 96.2 ± 0.6 %, compared to 
untreated cells. To exclude the possibility that emetine 
treatment effects were reversible during the course of IL-1 
mRNA induction experiments, 3H-leucine incorporations were 
assessed on cells collected after the completion of the IL-1 
induction cultures. 
Representative results from one of two experiments 
examining the effect of T cell protein synthesis inhibition 
on the induction of monocyte IL-1 mRNAs are shown in Figures 
13 and 14. Monocytes were cultured in the presence of anti-
CD3 plus emetine treated T cells and RNA collected at 4 and 
12 h evaluated by slot blot analysis for induction of monocyte 
IL-1 a and ~ mRNAs. Data for each IL-1 species were expressed 
as a percent IL-1 mRNA index relative to the maximum (100 %) 
levels induced by LPS at 4 h. Emetine treatment of T cells 
failed to inhibit IL-1 a and ~ mRNA induction at either the 
4 or 12 h time points. Direct effects on monocytes by emetine 
leaching from T cells were ruled out in control cultures based 
by the observation that induction of IL-1 by LPS was 
unaffected by the presence of emetine treated T cells. 
These results demonstrated that de novo protein 
synthesis was not required for T cell induction of IL-1 mRNA 
in monocytes during anti-CD3 mitogenesis. Furthermo~e, these 
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Figure 13. Induction of IL-1 a mRNA in Monocytes Stimulated 
With Anti-CD3 Plus Emetine Treated T Cells T cells, 
pretreated at the designated dose with emetine, an inhibitor 
of de nova protein synthesis, were evaluated for their ability 
to induce monocyte IL-1 a mRNA at 4 and 12 h in the presence 
of 50 ng/ml anti-CD3. Control cultures included monocytes 
stimulated with 10 µg/ml LPS, or LPS in the presence of high 
dose emetine treated T cells. Results were expressed as a 
percent IL-1 a mRNA Index relative to the maximum (100 %) 4 
h LPS inducible response. Representative results from one of 
two experiments are shown. 
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Figure 14. Induction of IL-1 8 mRNA in Monocytes stimulated 
With Anti-CD3 Plus Emetine Treated T Cells Cells were 
cultured and analyzed employing the same culture conditions 
described in the legend to Figure 13. Results were expressed 
as a percent IL-1 P mRNA Index relative to the maximum (100 
%) 4 h LPS (10 µ.g/ml) inducible response. Representative 
results from one of two experiments are shown. 
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results indicated that the acquisition of cell contact 
dependent IL-1 inducing activity occurred independently of 
protein synthesis. Finally, these experiments confirmed that 
the synthesis of soluble T cell lymphokines was not involved 
in the initial phase of induction of IL-1 mRNA in monocytes. 
protein Synthesis by T Cells Is Required for the Induction of 
IL-1 S Secretion by Monocytes 
Inasmuch as metabolically inactivated T cells were 
unable to induce secretion of IL-1 p by monocytes during anti-
CD3 mitogenesis, experiments were carried out to determine 
whether T cell protein synthesis was required for the 
secretion of IL-1 ~ during anti-CD3 mitogenesis. 
Results from two individuals depicting the effect of 
T cell protein synthesis inhibition on IL-1 ~ secretion during 
anti-CD3 mi togenesis are shown in Figure 15. These data 
demonstrated that emetine treatment of T cells inhibited IL-
1 p secretion into culture supernates in a dose dependent 
manner. Maximal inhibition at the highest emetine treatment 
dose was 90.4 %. Inhibitory effects due to leaching of 
emetine from T cells were not responsible for this 
observation, as demonstrated by the normal induction of IL-1 
p secretion by monocytes stimulated with LPS in the presence 
of emetine treated T cells. 
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Figure 15. Effect of Protein synthesis Inhibition on T Cell 
Mediated Induction of sIL-1 8 Cells were cultured for 48 h 
according to the legend to Figure 13 and sIL-1 p in supernates 
was quantitated using a specific ELISA. Results depict mean 
± S.E.M. sIL-1 p levels, expressed in pg/ml, from two 
experiments. 
101 
These results demonstrated that de novo protein 
synthesis was required by T cells to promote secretion of IL-
1 p by monocytes during anti-CD3 mitogenesis. In contrast, 
protein synthesis by T cells was not required for induction 
of the initial phase of monocyte IL-1 mRNA. 
Induction of Late Phase Monocyte IL-1 mRNA is Associated With 
the Appearance of IL-1 Inducing cytokines (IL-2, IFN-l and 
TNF-al in Anti-CD3 Mitogenic Culture Supernates 
The results from double chamber well experiments 
indicated the presence of a second, later phase of induction 
of monocyte IL-1 mRNA, which was mediated by soluble factors 
generated during anti-CD3 mi togenesis. Experiments were 
carried out to determine whether the kinetics of induction of 
late phase IL-1 mRNA induction correlated with the appearance 
of cytokines previously reported to possess IL-1 inducing 
activity (IL-2, IFN-i and TNF-a). 
IL-2, IFN- ~ and TNF-a in culture supernates were 
assessed at different time points of anti-CD3 rnitogenesis by 
specific irnrnunoassays and the results shown in Figure 16. 
These cytokines all exhibited similar kinetics of appearance 
in culture supernates. Whereas they were not detectable at 
early 2-4 h time points of anti-CD3 mitogenesis, pronounced 
levels were detected at L B h and reached maximal levels at 
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Figu.r.e 16. Kinetics of Apoearanca of IL-2, IFN- Y and TNl'-a 
in supernates of Anti-CD3 Mitogenic cultures cytokines were 
analyzed in supernates collected at the designated time points 
of anti-CD3 mitogenic culture by specific radioimmunoassays. 
Units of IL-2 and IFN- 0 activity were calibrated with respect 
to NIH BRMP IL-2 and NIH IFN-standards respectively. 
Representative results from one of three experiments are 
shown. N.D. = Not determined. 
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4S h. 
These results demonstrated that the IL-1 inducing 
cytokines, IL-2, IFN- 'ti and TNF-a, were not detectable in 
culture supernates at a time of anti-CD3 mitogenesis when 
significant levels of monocyte IL-1 mRNA were detectable (S 
4 h). The kinetics of appearance of cytokines were, however, 
temporally associated with the appearance of the late phase 
of monocyte IL-1 mRNA, at 12 h of culture. 
Induction of Monocyte IL-1 by T Cell subpopulations 
In view of previous experiments demonstrating a 
requirement for direct T cell monocyte contact for the initial 
induction of monocyte IL-1 mRNA, experiments were carried out 
to determine whether this IL-1 mRNA inductive signal was 
transduced during the major histocompatibility complex (MHC) 
class II restricted interaction between monocytes and co4• T 
cells. These experiments compared the ability of class II 
restricted CD4+ and class I restricted CDS+ T cell subsets to 
induce IL-1 mRNA during anti-CD3 mitogenesis. 
T cells were fractionated into co4• and cos• T cell 
subpopulations by negative selection employing magnetic beads 
and purity of final cell subpopulations was confirmed by flow 
cytometric analysis of CD4 and CDS cell surface marker 
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expression, as shown in Table 9. These data, summarized from 
three separate experiments, demonstrated that en4• enriched T 
cells contained 7.3 ± o.s % contamination by ens• cells and 
that CDS.. enriched T cells contained 5. 6 ± 2. 2 % 
contamination by CD4+ cells. Figure S of the Appendix shows 
contour plots illustrating cell surface marker expression of 
the CD4+ and cos• T cell subpopulations employed in the IL-1 
mRNA induction experiment depicted in Table 10. 
Monocytes cultured for 12 h in the presence of anti-
CD3 plus co4• or cos• T cell subsets were evaluated by slot 
blot analysis for detection of IL-1 a and ~ mRNAs, expressed 
as a percent IL-1 mRNA index for each IL-1 species relative 
to the maximum (100 %) level induced by LPS, as shown in Table 
10. These data, obtained from a single experiment, 
demonstrated that both cn4• and ens• T cell subsets were 
capable of inducing IL-1 a and p mRNAs in monocytes. ens• 
cells induced higher levels than cn4• cells of IL-1 a mRNA 
(149.0 % vs. 45.5 % of LPS inducible response) and IL-1 ~ mRNA 
(91.1 % vs. lS.2 %). 
These results demonstrated that, although the reasons 
for the quantitative differences between induction of IL-1 
mRNAs by co4• and ens• T cells remained unclear, induction of 
monocyte IL-1 mRNA was mediated by both co4• and cos• T cell 
subsets. Furthermore, these results indicated that 
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purity of CD4+ and CDS+ T Cells Isolated by Negative Selection 
% Positive Cells (Mean± S.E.M.) 
T Cells CD4+ CDS+ 
Unseparated 52.S ± 5.9 36.7 ± 1.9 
CD4+ 63.7 ± 6.S 7.3 ± 0.8 
CDS+ 5.6 ± 2.2 59.3 ± 3.8 
Table 9. Purity of T cell Subpopulations Isolated by Negative 
Selection. T cells were negatively selected into CD4+ and 
CDS+ T cell subpopulations using magnetic beads as described 
(see Materials and Methods). Results are presented as mean 
± S.E.M. percent cells positive for staining with fluorochrome 
conjugated anti-CD4 (FITC anti-Leu3 a&b) and anti-CDS (PE 
anti-Leu2 a) , obtained from three experiments. Representative 
flow cytometric contour plots illustrating cell surface marker 
expression of T cell subpopulations generated by negative 
selection are shown in Figure 5 of the Appendix. 
Induction of Monocyte IL-1 mRNA by CD4+ and CDS+ T Cells 
Monocytes plus: 
T Cells Stimulus 
Unseparated anti-CD3 
CD4+ anti-CD3 
CDS+ anti-CD3 
anti-CD3 
IL-1 mRNA Index 
(% of LPS response) 
IL-la IL-1~ 
75.6 4S.O 
45.4 lS.2 
149.0 91. l 
0 0 
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Table 10. Induction of IL-1 mRNA in Monocytes by CD4+ and 
CDS+ T Cells CD4+ and CDS+ T cell subpopulations were 
prepared by negative selection as described in the legend to 
Table 9 and compared for their ability to induce IL-1 mRNAs 
in monocytes at 12 h in the anti-CD3 mitogenesis model. The 
IL-1 mRNA content of monocytes was analyzed by slot-blot 
analysis, expressed as a percent IL-1 mRNA index for each IL-
1 species relative to the maximum (100 %) levels inducible by 
LPS (10 µg/ml). Results of a single experiment are shown. 
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transduction of the cell contact mediated IL-1 mRNA inductive 
signal was not mediated exclusively through the MHC class II 
restricted interaction between monocytes and CD4+ T cells. 
A second series of experiments were carried out to 
determine whether the IL-1 inductive signal could be generated 
by virgin, unprimed T cells or was confined to the previously 
primed T cell subset. These experiments compared the ability 
of positively selected naive (CD45RA+) and memory (CD45RO+) T 
cells to induce IL-1 ~ secretion by monocytes in a 
microculture anti-CD3 mitogenesis model. In addition, the 
initial experiments using negatively selected CD4+ and cos• T 
cell subsets were repeated in this second series of 
experiments, employing positively selected cells and secretion 
of IL-1 ~ as a measure of IL-1 induction. 
T cells were subfractionated into CD45RA+, CD45RO+, 
co4• and cos• T cell subpopulations by cell sorting and purity 
was cont irmed by phenotypic analysis. Results summarized from 
three experiments are shown in Table 11. 
each subpopulation obtained by cell 
Mean purities of 
sorting in these 
experiments was~ 9S.3 ± 0.7 %. Representative contour plots 
illustrating cell surface marker expression of the T cell 
subpopulations employed in these experiments are shown in 
Figure 6 of the Appendix. 
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Table 11. Purity of T Cell Subpopulations Isolated by 
Positive Selection. T cells were positively selected by 
staining with anti-CD45RA (FITC anti-Leu 18) and anti-CD45RO 
(PE UCHL-1) antibodies, or anti-CD4 (FITC anti-Leu3 a&b) and 
anti-CDB (PE anti-Leu 2a) antibodies, followed by cell 
sorting. Results are presented as mean ± S.E.M. of the 
percentage of percent cells positive for staining with each 
antibody, obtained from three experiments. Representative 
flow cytometric contour plots illustrating cell surf ace marker 
expression of T cell subpopulations generated by positive 
selection are shown in Figure 6 of the Appendix. 
Purity of T Cell Subpopulations Isolated by Positive Selection 
% Positive Cells (Mean± s.E.M.) 
T Cells CD45RA+ CD45RO+ CD4+ CDS+ 
Unseparated 38.1 ± 6.2 23.8 ± 5.5 63.4 ± 3.6 29.4 ± 4.4 
CD45RA+ 98.3 ± 0.3 0 
CD45RO+ 0 98.3 ± 0.3 
CD4+ 99.7 ± 0.3 0.3 ± 0.3 
CDS+ 0.3 ± 0.3 9S.3 ± 0.7 
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Ability of T Cell Subpopulations to Induce 
IL-1 ~ Secretion by Monocytes 
Monocytes Plus: sIL-1 ~ (Mean± S.E.M.) 
T Cells Stimulus (% of LPS Response) 
LPS 100 ± 0 
Unseparated Anti-CD3 69.0 ± 7.0 
CD45RA+ Anti-CD3 57.0 ± 11. 0 
CD45RO+ Anti-CD3 40.0 ± 6.4 
CD4+ Anti-CD3 44.5 ± 1. 5 
CD8+ Anti-CD3 46.0 ± 8.0 
Table 12. Ability of T Cell Subpopulations to Induce IL-1_§ 
Secretion by Monocytes CD45RA+, CD45RO+, CD4+ and CD8+ T cell 
subpopulations were obtained by positive selection as 
,, 
described in the legend to Table 11 and compared for their 
ability to induce sIL-1 ~ by monocytes in the anti-CD3 
mitogenesis model. Supernates were collected at 48 h of 
culture for detection of sIL-1 ~ by specific ELISA. Results 
depict mean ± S.E.M. levels of sIL-1 ~ contained in culture 
supernates established from two experiments, expressed as a 
percent of IL-1 ~ levels induced by LPS (10 µg/ml). · 
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Culture supernates, collected at 4S h from monocytes 
cultured in the presence of anti-CD3 plus CD45RA+, CD45RO+, 
CD4+ or CDS+ T cells, were analyzed for secreted IL-1 p levels 
by IL-1 P specific immunoassay and the results from two 
experiments are summarized in Table 12. These data, expressed 
as a percent of secreted IL-1 p induced by LPS, demonstrated 
that CD45RA+ and CD45RO+ T cells induced comparable secretion 
of IL-1 p by monocytes (57.0 ± 11.0 % vs. 40.0 ± 6.4 %) • 
These data also demonstrated that CD4+ and CDS+ T cells induced 
comparable secretion of IL-1 p by monocytes (44.5 ± 1.5 % vs. 
46.0 ± s.o %). 
These results demonstrated that comparable T cell IL-
1 inductive signals were generated by naive and memory T 
cells. These results also demonstrated that CD4+ and COB+ 
cells were both able to induce secretion of IL-1 p by 
monocytes, thus confirming previous observations at the mRNA 
level. 
Preliminary Examination of Monocyte Cell surface Molecules 
Capable of Transducing an IL-1 mRNA Inductive Signal 
Preliminary investigations were performed to 
characterize molecules on the monocyte cell surface capable 
of transducing an IL-1 mRNA inductive signal. Initial studies 
were carried to determine whether monocyte MHC class I and II 
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Table 13. Induction of IL-1 8 mRNA in Monocytes by Monoclonal 
Antibodies Total cellular RNA was extracted from monocytes 
stimulated for 4 or 12 h with 10 µg/ml LPS or 80 µg/ml protein 
containing (NH4 ) 2so4 preparations of anti-HLA-DR (L243; IgG2a), 
anti-HLA-A,B,C (W6/32; IgG28 ) or anti-CD14 (6303; IgG1) 
monoclonal antibodies. The IL-1 mRNA content of monocytes was 
analyzed by slot-blot analysis and was expressed both as an 
IL-1 p mRNA index and as a percent IL-1 p mRNA index relative 
to the maximum (100 %) LPS inducible responses. Results of 
two experiments are shown. N.D. = Not determined. 
stimulus 
LPS 
Anti-HLA-DR 
Anti-HLA-A,B,C 
Anti-CD14 
Induction of IL-1 ~ mRNA in Monocytes by Monoclonal Antibodies 
IL-1 ~ mRNA Index % of LPS Response 
Time (h) Expt.l Expt.2 Expt.l Expt.2 
4 4.6 4.7 100.0 100.0 
12 5.8 N.D. 100.0 N.D. 
4 9.1 3.9 197.8 83.l 
12 17.9 N.D. 308.6 N.D. 
4 1.5 N.D. 32.6 N.D. 
12 1. 9 N.D. 32.8 N.D. 
4 1. 7 N.D. 37.0 N.D. 
12 0.9 N.D. 15.5 N.D. 
...... 
...... 
w 
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molecules could act as IL-1 signal transducing moieties. 
In these experiments, anti-class I (HLA-A,B,C) and 
class-II (HLA-DR) antibodies were compared with LPS for their 
ability to induce IL-1 ~ mRNA in monocytes at 4 and 12 h, as 
shown in Table 13. In two separate experiments, anti-HLA-DR 
antibody (L243 mAb, IgG2a), employed at 80 µg/ml protein in an 
(NH4 ) 2S04 preparation, induced IL-1 P mRNA levels between 83.1 
and 328.0 % of LPS inducible levels. Stimulation occurred in 
the absence of detectable endotoxin levels (~ 5 pg/ml) in 
antibody preparations. In a single experiment, an anti-HLA 
class I framework antibody (W6/32 mAb, IgG2a), employed as an 
(NH4 ) 2so4 preparation at the same concentration as L243, 
induced IL-1 P mRNA at levels between 33.0 and 36.0 % of those 
induced by LPS. In control cultures, an irrelevant monocyte 
specific anti-CD14 (6303 mAb, IgG1 ) antibody, employed at the 
same concentrations as L243, also induced IL-1 p mRNA at 
levels between 17.0 and 37.0 % of those induced by LPS. 
Initial results examining monocyte cell surface 
molecules capable of transducing an IL-1 mRNA inductive 
signals demonstrated that any of a number of monocyte surface 
antigens were capable of transducing an IL-1 p mRNA inductive 
signal when stimulated by specific monoclonal antibody. 
DISCUSSION 
The overall objective of this investigation was to 
study the signals that regulate the induction of IL-1 during 
an immune response. According to the previously proposed 
hypothesis, this induction is not constitutive and likely to 
take place during the antigen specific interaction between 
monocytes and T cells during an immune response. To address 
whether T cells induce monocyte IL-1 during a primary immune 
response, this investigation evaluated the ability of normal 
human T cells, activated by anti-CD3 antibody in a model of 
primary immune activation, to induce the production of IL-1 
by autologous human monocytes. These studies assessed 
induction of IL-1 both at the mRNA and secreted levels. 
Through the use of purified normal cell populations and the 
analysis of IL-1 at both the mRNA and secreted product levels, 
this investigation has identified distinct T cell signals 
which regulate the induction of IL-1 at distinct stages during 
an immune response. 
The purity of the cell populations used represented a 
critical component for the performance of these studies. 
Inasmuch as the characterization of T cell signals leading to 
the induction of monocyte IL-1 necessitated that other cell 
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types were eliminated from experimental cultures, procedures 
were required for the routine isolation of highly purified 
monocyte and T cell populations from human peripheral blood. 
T cell populations used in these studies were 
demonstrated to be pure based on phenotypic analysis. More 
importantly, purified T cells exhibited only 2.2 % of control 
proliferative responses when stimulated by the monocyte 
dependent T cell mitogen, Con A. This provided a more 
stringent confirmation of T cell purity than phenotypic 
analysis. Similarly, purified monocyte populations were shown 
by phenotypic and functional analyses to contain < 2 % T cell 
contamination and exhibit < 1 % of proliferative responses 
exhibited by unseparated cells activated by anti-CD3 T cell 
mitogen. Cocultures of purified T cells and monocytes, 
however, exhibited completely restored anti-CD3 induced 
proliferative responses, demonstrating that when added 
together, highly purified T cells and monocytes were capable 
of generating the costimulatory signals necessary for the 
induction of T cell proliferation. Cell populations purified 
in this manner were therefore suitable for the study of T cell 
signalling events leading to the production of monocyte IL-1 
during a primary immune activation. 
To enable resolution of early IL-1 inductive signalling 
events, particular emphasis was placed in this investigation 
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on evaluating IL-1 production at the mRNA level. Inasmuch as 
previous reports have demonstrated the existence of multiple 
posttranslational processing steps during the production of 
IL-1 by monocytes, steady state IL-1 mRNA levels provided a 
more suitable measure than secreted IL-1 levels for the 
identification of the initial IL-1 inducing signals. 
Furthermore, induction of both IL-1 species (IL-1 a and IL-1 
{3) could be unambiguously investigated at the mRNA level 
without the need to measure secreted and membrane associated 
IL-1 activities of mature IL-1 a and {3 protein products. 
Levels of monocyte IL-1 a and {3 mRNAs were quantitated 
in this investigation through the use of a consti tu ti ve 
control gene, which allowed hybridization signal intensities 
among samples to be normalized with respect to the quantities 
of RNA attached to membranes. The mouse histone replacement 
variant H3.3 gene (121) (98 % homologous to the human H3.3 
gene) was chosen as a constitutive control gene for this 
purpose, as other more conventional cons ti tu ti ve control 
genes, such as actin and {3-tubulin, have been shown to be 
expressed at elevated levels in activated monocytes as a 
consequence of the changes in cytoskeletal architecture that 
accompany monocyte activation (113, 127). The validity of 
H3. 3 as a constitutive control gene in these studies was 
confirmed by the demonstration that the H3. 3 mRNA levels 
remain unchanged between unstimulated and LPS or anti-CD3/T 
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cell stimulated monocytes in the study group as a whole. These 
observations are consistent with a prior report which 
demonstrated the constant expression of the H3.3 gene, 
regardless of cell cycle or differentiation state of cells 
(128). 
The study of lymphocyte mediated IL-1 production at the 
mRNA level necessitated that monocytes expressed no detectable 
background IL-1 mRNA. Inasmuch as previous reports have 
demonstrated that adherence to plastic alone stimulated 
monocytes to express IL-1 mRNA (129) and secreted IL-1 (130), 
initial experiments were performed to investigate the kinetics 
of adherence-induced monocyte IL-1 mRNA expression. IL-1 
mRNAs were detectable in freshly isolated monocytes prior to 
adherence. Despite an initial induction of monocyte IL-1 a 
and p mRNA expression following isolation and/or adherence, 
IL-1 mRNAs returned to undetectable levels by 48 h of culture. 
This induction occurred in the absence of detectable endotoxin 
levels in any of the reagents employed during the purification 
of monocytes. Previous reports have employed in situ 
hybridization analysis to demonstrate that unstimulated 
circulating human blood monocytes do not express IL-1 mRNAs 
(97). The observed expression of monocyte IL-1 mRNA prior to 
adherence was therefore most likely stimulated during the 
extensive cell purification procedures employed in the current 
studies, similar to the reported Percell-mediated induction 
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of the c-fos cellular proto-oncogene in human monocytes (131). 
The kinetics of adherence-induced monocyte IL-1 mRNAs indicate 
that monocytes cultured for at least 48 h prior to the 
addition of stimuli exhibit negligible levels of IL-1 mRNA 
and are therefore suitable for subsequent studies examining 
T cell mediated triggering of monocyte IL-1 mRNA. 
Inasmuch as previous reports have failed to detect 
intracellular IL-1 f3 induced in monocytes during anti-CD3 
mitogenesis (109), experiments were performed to determine 
whether IL-1 a and f3 mRNAs were induced in monocytes following 
the addition of T cells plus anti-CD3 in the anti-CD3 
mitogenic response. In contrast to a previous report (109), 
this study shows the rapid and pronounced induction of IL-1 
a and f3 mRNAs in human monocytes stimulated by the addition 
of T cells plus anti-CD3, but not by the addition of T cells 
alone or anti-CD3 alone. This observation suggests that T 
cells activated during anti-CD3 mitogenesis are capable of 
delivering a monocyte IL-1 mRNA inductive signal. These 
results also demonstrate that the observed monocyte IL-1 mRNA 
inductive effects are not mediated directly by the binding of 
anti-CD3 antibody alone to monocyte Fe receptors. This 
finding is consistent with a previous report examining direct 
Fe receptor mediated induction of IL-1 mRNA in human 
monocytes, which showed that antibody concentrations three 
orders of magnitude greater than those employed in the current 
l~O 
studies were required to induce IL-1 mRNA in monocytes (132). 
previous studies (109) examining the induction of 
intracellular IL-1 f3 in human monocytes during anti-CD3 
mitogenesis demonstrated that, whereas IL-1 was induced in 
monocytes following the addition of activated T cell blasts 
in a secondary anti-CD3 mitogenesis response, no such 
induction was observed during a primary anti-CD3 mitogenesis, 
employing the same antibody and model of anti-CD3 mitogenesis 
as employed in the current investigation. An explanation for 
the discrepancy in results reported by the previous study and 
the current investigation, based on a technical difficulty 
experienced by the previous investigators in determining 
intracellular IL-1 f3 levels, was strongly suggested by the 
inconsistent observation contained in the previous study that 
IL-1 P was induced in anti-CD3 mitogenesis cultures at the 
secreted but not intracellular level. In contrast, the 
current results suggest that the induction of IL-1 mRNA is not 
confined to secondary immune responses, but can be mediated 
during the interaction between monocytes and T cells 
stimulated in a model of primary immune activation. Inasmuch 
as previously primed T cells in peripheral blood also may 
participate in anti-CD3 mitogenesis (133), this experiment 
does not specifically address whether IL-1 inductive signals 
can be generated by previously unprimed T cells. 
Rapid induction kinetics of monocyte IL-1 mRNAs are 
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observed during anti-CD3 mitogenesis, with detectable levels 
present as early as 1 h and peak levels present at 12 h 
following the addition of T cells plus anti-CD3 to monocytes. 
These rapid induction kinetics are consistent with the 
assumption that T cells transduce the IL-1 mRNA inductive 
signal through direct cell contact with monocytes. This 
conclusion is consistent with the induction kinetics of mIL-
1 previously reported by Wasik and Beller (108), which 
described a rapid(~ 4 h), cell contact mediated induction of 
membrane IL-1 on mouse macrophages stimulated by the addition 
of autoreactive T cell clones. The rapid induction of IL-1 
mRNA during anti-CD3 mitogenesis further suggests that T cells 
acquire IL-1 inducing capacities very soon after cross-linking 
and triggering of the CD3/TCR complex. The similar induction 
kinetics for IL-1 a and IL-1 13, observed throughout this 
investigation, is consistent with a coordinate regulation of 
both IL-1 species during anti-CD3 mitogenesis. 
The signals leading to the induction of monocyte IL-1 
rnRNAs during anti-CD3 mitogenesis appear relatively potent, 
in that they achieve approximately 40 % of the levels of IL-
1 mRNA induced by LPS. Relative to the LPS stimulus for each 
IL-1 species, IL-1 a mRNA levels induced during anti-CD3 
rnitogenesis were slightly higher than relative IL-1 /3 mRNA 
levels. However, consistent with previous reports 
demonstrating that IL-1 /3 comprised the major species of IL-
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1 induced at the absolute mRNA level in LPS stimulated 
monocytes {50), an examination of IL-1 P and IL-1 a 
hybridization signal intensities at comparable exposure times, 
assuming approximately similar specific probe activities and 
optimal wash stringencies for each probe, reveals that IL-1 
~ mRNA appears to be the more abundant mRNA species induced 
by either LPS or anti-CD3 mitogenic stimuli. Additionally, 
induction of IL-1 mRNAs during anti-CD3 mitogenesis was 
limited to the monocyte population. In contrast to previous 
reports employing activated T cell clones (134), no IL-1 mRNAs 
were detectable in activated T cells purified from anti-CD3 
mitogenesis cultures. Collectively, these observations show 
that levels of IL-1 a and ~ mRNA induced in monocytes during 
anti-CD3 mitogenesis are relatively substantial compared to 
those induced by LPS. 
Inasmuch as previous reports have established an 
obligatory role for monocyte Fe receptors during the cross 
linking of CD3/anti-CD3 complexes in anti-CD3 mitogenesis 
(119), the possibility that induction of IL-1 mRNA was 
mediated through the binding of anti-CD3/T cell complexes to 
monocyte Fe receptors was examined. To determine whether 
induction of IL-1 during anti-CD3 mitogenesis was mediated 
through the binding of antibody/T cell complexes to monocyte 
Fe receptors or occurred instead through the required 
activation of T cells, experiments were performed in which a 
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non-mitogenic T cell specific anti-CD5 antibody, of the same 
IgG28 isotype as anti-CD3, was substituted in place of anti-
CD3. Results show that anti-CD5 is incapable of providing the 
necessary stimulus for the induction of monocyte IL-1 mRNA in 
the presence of T cells, indicating that IL-1 mRNA induction 
during anti-CD3 mitogenesis requires a T cell activation event 
and is not mediated solely a result of binding of antibody/T 
cell complexes to monocyte Fe receptors. 
In view of previous observations that monocytes can 
transcribe IL-1 mRNA in the absence of IL-1 secretion (59), 
it was necessary to determine whether the observed induction 
of monocyte IL-1 mRNA by T cells plus anti-CD3 was associated 
with secreted IL-1 activity. These experiments show that 
serologic IL-1 p activity is present as early as 4 h and peaks 
at ~ 48 h in anti-CD3 culture supernates. Detection of 
biologic IL-1 activity in supernates, assessed by the LBRM-
33-1A5 conversion bioassay (125), confirms that the induction 
of IL-1 mRNA during anti-CD3 mitogenesis is accompanied by the 
secretion of a biologically active product. 
Secreted IL-1 a activity was not detected in anti-CD3 
mi togenesis culture supernates. This observation is 
consistent with a large body of evidence (56, 57, 60) which 
demonstrates that mature IL-1 a is not secreted 
extracellularly but remains associated with the monocyte cell 
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membrane. Membrane IL-1 activities of monocytes stimulated 
during anti-CD3 mitogenic culture were not determined in the 
present studies. Thus al though soluble IL-1 a was not 
detected, it remained possible that IL-1 a activity was 
induced during anti-CD3 mitogenesis but remained associated 
with the monocyte cell membrane. 
A significant lag between peak induction of IL-1 f3 mRNA 
at 12 h and peak secreted IL-1 /3 levels at ~ 48 h is observed 
during anti-CD3 mitogenesis. Previously discussed reports 
have demonstrated that multiple posttranslational processing 
steps are involved in the secretion of IL-1 from LPS 
stimulated monocytes (55, 59, 127, 135). Consistent with 
these reports, the observed lag between induction at the 
monocyte IL-1 mRNA level and secreted IL-1 f3 level may be 
explained by a model in which IL-1 f3 mRNA, initially induced 
during anti-CD3 mitogenesis, is translated into the 31 kD IL-
1 /3 precursor and stored in the cytoplasm until the monocyte 
receives sufficient activation signals to processes the 
precursor to the secreted 17 kD IL-1 f3 molecule. 
Interestingly, despite the fact that, in all 
experiments, levels of IL-1 f3 mRNA induced by LPS were greater 
than those induced by anti-CD3 mitogenesis, levels of IL-1 f3 
secreted into culture supernates during anti-CD3 mitogenesis 
are comparable to levels secreted by LPS stimulation of 
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monocytes. These observations suggested that anti-CD3 
activated T cells or their soluble products may be involved 
in promoting secretion of IL-1 f3 from monocytes containing IL-
1 mRNA transcripts. 
To determine whether the observation of IL-1 induction 
during anti-CD3 mitogenesis could be repeated in an antibody-
independent model of an immune response, experiments were 
performed to measure the synthesis of IL-1, both at the mRNA 
and secreted levels, during a primary allogeneic mixed 
lymphocyte response (MLR). The allogeneic MLR represents a 
model of a primary immune response in which T cells are 
activated directly through their antigen receptors by 
recognition of allogeneic class II MHC antigen on the cell 
surface of allogeneic monocytes. The allogeneic MLR therefore 
provides an antibody-independent model of immune activation. 
The results show that induction of IL-1 occurs both at 
the mRNA and secreted levels during an allogeneic MLR, thereby 
providing separate evidence in an antibody-independent model 
of an immune response to support the earlier induction of 
monocyte IL-1 observed during anti-CD3 mitogenesis. Previous 
reports examining the induction of IL-1 in human monocytes 
during a primary allogeneic MLR have yielded contradictory 
results. Whereas Dinarello and Kent (105) reported induction 
of secreted IL-1 activity in primary allogeneic MLR cultures, 
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Bhardwaj and Steinman (109) failed to observe induction of 
secreted IL-1 during a primary MLR, but did observe induction 
of IL-1 during a secondary MLR. These authors use this 
observation to support their previous view, obtained in murine 
anti-CD3 mitogenesis responses in the mouse, that induction 
of IL-1 is not a component of primary immune responses. The 
current findings support the previous detection of secreted 
IL-1 during a primary human MLR reported by Dinarello et al., 
but contradict the inability to detect IL-1 during a primary 
MLR reported by Bhardwaj and Steinman. 
To determine whether the monokine IL-6, which acts 
synergistically with IL-1 to costimulate T cell activation, 
was coinduced with IL-1 during anti-CD3 mitogenesis, an 
initial experiment was carried out to examine the induction 
of IL-6 mRNA in monocytes during anti-CD3 mitogenesis. The 
results demonstrate that IL-6 mRNA is co induced with IL-1 
during anti-CD3 mitogenesis. These results demonstrate that 
IL-6 mRNA may require the same T cell signals as IL-1 for 
induction. Furthermore, these observations are consistent 
with a model in which the synergistically acting costimulatory 
molecules, IL-1 and IL-6, are simultaneously induced at the 
site of an immune response during the antigen-specific 
interaction between T cells and monocytes during an immune 
response. 
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Having established that signals from activated T cells 
mediate the induction of monocyte IL-1 mRNAs and secreted IL-
1 ~, subsequent experiments were designed to characterize the 
nature of the T cell derived stimulatory signal. 
The rapid induction kinetics of IL-1 mRNA observed 
during anti-CD3 mitogenesis were consistent with a requirement 
for cell contact between T cells and monocytes for 
transduction of the IL-1 inductive signal. A cell contact 
requirement was therefore examined through the use of double 
chamber culture wells, in which monocytes cultured in separate 
chambers were exposed to two different sets of signals. 
Monocytes exposed to these two sets of signals exhibit 
strikingly different kinetics and magnitude of IL-1 mRNA 
responses. Monocytes cul tu red in upper chambers, which 
received signals obtained through direct cell contact with T 
cells, demonstrate a rapid and pronounced induction of IL-1 
mRNA, detectable at 2 h and peaking at 12 h, characteristic 
of the response previously observed during anti-CD3 
mitogenesis. In contrast, monocytes cultured in lower 
chambers, which were exposed only to the soluble signals 
generated during anti-CD3 mitogenesis exhibit no detectable 
IL-1 mRNA at early 2 and 4 h time points, but do exhibit low 
levels of IL-1 mRNA at ~ 12 h. Control experiments verified 
that the low levels of IL-1 mRNA induction observed in lower 
chamber rnonocytes were not caused by an anti-CD3 mitogenesis 
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response with residual T cells contaminating this chamber. 
Two distinct phases of induction of IL-1 mRNA during 
anti-CD3 mitogenesis were also identified by these studies. 
First, a pronounced initial phase, which occurs in the 
presence of cell contact between T cells and monocytes, and 
second, a low level late phase, which occurs as a result of 
soluble signals generated during anti-CD3 mitogenesis. The 
initial triggering phase of monocyte IL-1 mRNA, which occurs 
in the presence of cell contact between T cells and monocytes, 
has been extensively characterized in this investigation and 
will be discussed later. The late phase of induction of IL-
1 mRNA, mediated by soluble factors generated during anti-CD3 
mi togenesis, was further investigated. Experiments were 
performed to determine whether the kinetics of induction of 
late phase monocyte IL-1 mRNA correlated with the appearance 
in culture supernates of the late phase cytokines IL-2, IFN-
l and TNF-a:, which have been previously recognized to possess 
IL-1 inducing activities (115-117). 
The IL-1 inducing cytokines, IL-2, IFN-'t and TNF-a:, all 
exhibit similar kinetics of appearance in anti-CD3 mitogenic 
culture supernates. Whereas they are not detectable at early 
2 - 4 h time points, pronounced levels are detected at ~ 8 h 
and reach maximal levels at 48 h. These results show that 
the appearance of IL-1 inducing cytokines is temporally 
130 
experiments were designed to evaluate the ability of 
metabolically inactivated T cells to induce IL-1 rnRNAs through 
direct cell contact with monocytes. 
Results of these experiments show that T cells, 
metabolically inactivated by paraforrnaldehyde fixation, are 
fully capable of inducing both IL-1 a and # mRNAs in monocytes 
in the presence of anti-CD3, but only when these cells had 
been preactivated. These observations demonstrate that cell 
contact alone with appropriately activated T cells is required 
for the initial induction of monocyte IL-1 rnRNA during anti-
CD3 mi togenesis. Furthermore, these results def ini ti vely rule 
out the involvement of soluble T cell factors in this initial 
triggering of IL-1 mRNA. An evaluation of T cell fixation 
conditions verified that paraformaldehyde fixation resulted 
in complete loss of cell viability, as judged by flow 
cytometric analysis of PI vital dye exclusion. 
Direct effects of T cell fixation upon monocytes were 
ruled out by the inability of fixed, unstimulated T cells to 
induce monocyte IL-1 mRNAs in the presence of anti-CD3. The 
inability of fixed, unstimulated T cell to induce monocyte 
IL-1 mRNA also supports the conclusion of a previous 
experiment employing non-mi togenic anti-CD5 antibody, that 
inauction of IL-1 mRNA during anti-CD3 mi togenesis occurs 
through a required T cell activation event. Wherea? fixed, 
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unstimulated T cells do not induce monocyte IL-1 mRNA in the 
presence of anti-CD3, fixed preactivated T cells are capable 
of induction of monocyte IL-1 mRNA. These results are 
consistent with previous results obtained using T cells plus 
a non-mitogenic anti-CD5 antibody and demonstrate that 
induction of monocyte IL-1 mRNA during anti-CD3 mitogenesis 
occurs as a result of activation of T cells and not through 
the binding of antibody/T cell complexes to monocyte Fe 
receptors. 
The ability of fixation to maintain cell surface 
determinants at a given stage of T cell activation was 
utilized in these studies to characterize the activation 
signals required for acquisition of IL-1 inducing properties 
at the T cell surface. Three groups of fixed T cells, 
differing in their activation state prior to fixation, were 
investigated for their ability to trigger IL-1 mRNA in 
rnonocytes. These groups consisted of unstimulated T cells, 
T cells activated by immobilized anti-CD3 for 24 h and T cells 
activated by monocytes plus anti-CD3 for 24 h. Results show 
that fixed T cells, preactivated either by immobilized anti-
CD3 or monocytes plus anti-CD3, induce monocyte IL-1 mRNA, 
whereas fixed, unstimulated T cells do not. Proliferative 
responses demonstrate that T cells activated with monocytes 
plus anti-CD3 exhibit the complete proliferative capacity 
expected of combined monocyte, T cell populations activated 
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in an anti-CD3 mitogenesis. T cells in this group had 
therefore received the TCR complex triggering signal and all 
monocyte derived costimulatory signals. T cells which were 
stimulated by immobilized anti-CD3 alone, exhibited < 5 % of 
the anti-CD3 mitogenic response. However, in the presence of 
exogenously added IL-2, proliferative responses of these T 
cells were completely restored. This observation demonstrates 
that T cells activated by immobilized anti-CD3 had received 
sufficient activating signals to express IL-2 receptors, but 
insufficient signals to generate IL-2 and become fully 
activated. Previous reports have demonstrated that TCR 
complex triggering culminates in the expression of IL-2 
receptors (66) and that soluble costimulatory signals are 
required for elaboration of IL-2 and subsequent clonal 
proliferation of triggered T cells (67). Proliferative 
responses of T cells stimulated by immobilized anti-CD3 
therefore indicate that these cells had received the TCR 
triggering signal only. In conclusion, experiments examining 
the activation signals required by T cells for generation of 
IL-1 mRNA inductive capacity demonstrate that TCR triggering 
alone provides sufficient stimulus for transduction of the IL-
1 mRNA inductive signal. 
Early acquisition of T cell IL-1 mRNA inductive 
properties following the TCR triggering signal alone is 
consistent with the rapid induction at ~ 1 h of monocyte IL-
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1 mRNA during anti-CD3 mitogenesis. These rapid induction 
kinetics preclude the possibility that T cells must receive 
monocyte derived costimulatory signals and become fully 
activated prior to transduction of the IL-1 mRNA inductive 
signal. In support of this notion, the induction of IL-1 mRNA 
at 1 h precedes the earliest reported detection of IL-2 during 
anti-CD3 mitogenesis by 3 - 7 h (67, 136). The signalling 
requirements for T cells and the kinetics of transduction of 
the IL-1 mRNA inductive signal are also consistent with the 
previously reported and well established sequence of 
signalling events required for the complete activation of T 
cells during an antigen specific immune response (63-67). As 
previously discussed, IL-1 plays its preponderant 
costimulatory role during the activation of human T cells at 
the level of IL-2 production (80, 81). Early transduction by 
the T cell of the IL-1 mRNA inductive signal, before the 
production of IL-2, is therefore chronologically consistent 
with a subsequent role for IL-1 in the synthesis of IL-2. 
Despite being fully capable of inducing monocyte IL-1 
mRNA, fixed, preactivated T cells are incapable of inducing 
secretion of IL-1 ~ by monocytes. These results demonstrate 
that metabolic activity by T cells is required to induce IL-
1 ~ secretion by monocytes. Furthermore, this observation is 
consistent with a requirement for soluble T cell factors to 
induce secretion of IL-1 ~ by monocytes. This significant 
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finding is discussed in greater detail following an evaluation 
of the protein synthesis requirement of T cell mediated 
induction of IL-1 P secretion. 
Inasmuch as earlier experiments employing fixed T cells 
have demonstrated that novel IL-1 mRNA inducing properties are 
generated at the T cell surface following triggering of the 
TCR complex, experiments were performed to determine whether 
de !lQY.Q protein synthesis was required for acquisition of this 
IL-1 mRNA inductive property. These experiments evaluate 
whether the IL-1 mRNA inductive signal is generated de !lQY.Q 
or whether it preexists at the T cell surface, requiring only 
modulation or conformational change for transduce a signal. 
The protein synthesis requirement of the IL-1 mRNA inductive 
property was investigated by evaluating the ability of T 
cells, pretreated with the de novo protein synthesis inhibitor 
emetine, to induce monocyte IL-1 mRNA during anti-CD3 
mitogenesis. Results show that T cells pretreated with 
emetine are fully capable of inducing monocyte IL-1 a and P 
mRNA in the presence of anti-CD3. These studies demonstrate 
that de !lQY.Q protein synthesis is not required by T cells to 
transduce the cell contact mediated IL-1 mRNA inductive signal 
to monocytes during anti-CD3 mitogenesis. Furthermore, these 
observations support the conclusion from T cell fixation 
studies that synthesis of soluble T cell lymphokines is not 
involved in the initial phase of induction of monocyte IL-1 
l:J5 
mRNA. Finally, these findings suggest that the IL-1 inductive 
molecule possesses a slow turnover rate. Completeness of de 
nova protein synthesis inhibition was confirmed in these 
studies by assessments of 3H-leucine incorporation, which 
demonstrated that emetine treated T cells exhibited between 
94 - 96 % inhibition of de nova protein synthesis. Previous 
studies have reported that IL-1 production by monocytes is 
super induced in the presence protein synthesis inhibitors 
(137). However, direct effects on monocytes by emetine 
leaching from T cells were ruled out in the current 
experiments by control cultures, which demonstrated the normal 
induction of monocyte IL-1 mRNA by LPS in the presence of 
emetine treated T cells. In summary, de novo protein 
synthesis was not required for transduction of the cell 
contact mediated IL-1 mRNA inductive signal by T cells. 
The characteristics of the T cell IL-1 mRNA inductive 
signal identified in this investigation suggests that this 
signal represents the initial IL-1 inductive stimulus provided 
to the monocyte during an immune response. According to the 
previously proposed hypothesis, the initial IL-1 inductive 
signal during an immune response to foreign antigen is thought 
to be transduced by the T cell during its antigen specific 
interaction with the presenting monocyte. The basic 
components of the T cell IL-1 mRNA inductive signal described 
in this investigation, including rapid kinetics of 
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transduction, requirement for cell contact, acquisition 
following TCR triggering alone and independence of de nova 
protein synthesis, are all consistent with this model of 
initial IL-1 induction during an immune response. This 
investigation is the first to report the induction of IL-1 
mRNA in monocytes mediated by a T cell signal requiring cell 
contact. The similar induction requirements for IL-1 a and 
IL-1 ~ mRNA species observed in these studies, suggests that 
the initial inductive signals for each species is the same. 
The basic characteristics of the IL-1 mRNA inductive signal 
identified in this investigation are consistent with two 
previous reports in the literature, which have described cell 
contact mediated mIL-1 inductive signals generated by antigen 
specific or autoreactive mouse T cell clones, similarly 
insensitive to protein synthesis inhibitors (107, 108). A 
comparison between the T cell mIL-1 inductive signal reported 
by Wasik and Beller (108) and the IL-1 mRNA inductive signal 
reported in this investigation suggests that these signals 
may be the same. The requirements of these two T cell signals 
are identical with respect to cell contact, de D.QY.Q protein 
synthesis and metabolic activity. Whereas the use of mouse 
T cell clones in the previous investigations left unresolved 
whether IL-1 inductive signals could be transduced by normal 
polyclonal cell populations, the current studies have 
demonstrated that normal human T cells are capable of 
transducing the initial IL-1 inductive signal to monocytes 
through direct cell contact. 
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Importantly, the T cell 
activation signals required for transduction of this signal 
have also been defined in this investigation. Whereas the 
current investigation has determined that TCR triggering alone 
is a sufficient stimulus for T cells to transduce the IL-1 
mRNA inductive signal to monocytes, the two previous studies 
were unable to resolve the activation signals required at the 
level of the T cell, as they employed T cell clones 
constitutively maintained in the presence of stimulating 
antigen and feeder cells to provide costimulatory molecules. 
This investigation has therefore characterized several novel 
features of the T cell signal that mediates the initial 
induction of IL-1 mRNA in monocytes. 
Inasmuch as experiments in the current investigation 
demonstrated that protein synthesis was not required by T 
cells for induction of IL-1 ~ mRNA, a requirement for protein 
synthesis for T cell mediated induction of IL-1 ~ secretion 
by monocytes was investigated. Experiments were therefore 
performed to evaluate the ability of T cells, pretreated with 
the protein synthesis inhibitor emetine, to induce IL-1 ~ 
secretion by monocytes in the anti-CD3 mitogenesis model. 
The results demonstrate that, despite the presence of 
IL-1 ~ mRNA transcripts in monocytes, secretion of IL-1 ~ 
requires the presence of a T cell product which is dependent 
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upon de novo protein synthesis for its generation. A direct 
effect on monocytes by emetine leaching from T cells was ruled 
out by control cultures, which demonstrated that the LPS 
induced secretion of IL-1 ~ by monocytes was unaffected by the 
presence of emetine treated T cells. The presence of low 
levels of IL-1 ~ secreted independently of protein synthesis 
in T cells could not be completely ruled out by these studies. 
At the highest dose of emetine, which inhibited 96 % of T cell 
de novo protein synthesis, residual secreted IL-1 ~ levels of 
10 % were detected. The observation that T cell protein 
synthesis is required for induction of secreted IL-1 ~ by 
monocytes confirms and enlarges upon the previous observation 
of this current investigation that metabolically inactivated 
T cells were incapable of inducing IL-1 ~ secretion despite 
inducing monocyte IL-1 ~ mRNA. Furthermore, these 
observations suggest that activated T cell lymphokines are 
required to induce secretion of IL-1 ~ by monocytes. This 
possibility is consistent with previous reports which have 
identified IL-1 inducing properties exhibited by the late 
phase cytokines IL-2, IFN-~, TNF-a and IL-1 IF (115-117). 
Simultaneous analysis of IL-1 at the mRNA and secreted 
levels has led to the identification of two distinct stages 
of IL-1 production during anti-CD3 mi togenesis, each requiring 
a separate T cell inductive signal. First, the initial 
triggering of monocyte IL-1 mRNA is induced by a cell contact 
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mediated T cell signal generated independently of protein 
synthesis. Second, s·ecretion of IL-1 f3 by monocytes is 
induced by a T cell product whose generation is dependent upon 
de novo protein synthesis. Characteristics of the initial 
IL-1 mRNA triggering signal have been previously discussed. 
Several properties of the secreted T cell product that 
is required for IL-1 f3 secretion by monocytes, have been 
characterized by earlier experiments in this investigation and 
by previous reports in the literature. Experiments which 
showed a requirement for de novo protein synthesis to generate 
this T cell factor, suggest that this T cell product is a 
lyrnphokine, although the possibility of a de novo induced cell 
surface determinant cannot be excluded in these experiments. 
However, studies employing fixed, preactivated T cells argue 
against this second possibility, as the expression of such a 
cell surf ace determinant would be expected to be preserved 
following fixation. In support of this assumption, fixation 
did not alter the ability of T cells to transduce the cell 
associated IL-1 mRNA inductive signal to monocytes. The 
lyrnphokine hypothesis is consistent with previous reports in 
the literature, which have identified numerous lyrnphokines, 
including IL-2, IFN- ~ , TNF-a and IL-1 IF, which possess 
secreted IL-1 inducing properties (114-117). Synthesis of all 
of these lymphokines has been shown to be dependent upon de 
novo protein synthesis and, therefore, any combin_ation of 
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these lymphokines represent potential candidates as the 
secreted IL-1 inducing T cell factor identified by this 
investigation. 
The activation requirements for synthesis of this 
secreted IL-1 /3 inductive T cell factor are currently unknown. 
Kinetic studies of IL-1 /3 secretion during anti-CD3 
mitogenesis show that secreted IL-1 /3 is first detectable in 
culture supernates at 4 h. These kinetics argue neither for 
or against a requirement for TCR triggering in the absence of 
costimulatory molecules. Indirect evidence from the 
literature suggests that T cells require a minimum of TCR 
triggering plus the presence of monocyte membranes for 
synthesis of soluble IL-1 inducing lymphokines. With one 
exception, all previously identified IL-1 inducing lymphokines 
are late phase cytokines, which require both TCR triggering 
and costimulatory molecules for synthesis. The exception 
noted concerns the recently identified membrane IL-1 inducing 
lymphokine, IL-1 IF, which requires only mitogen and the 
presence of fixed macrophage membranes for its release from 
T cell clones (114). Therefore, although no direct evidence 
exists to indicate what signalling requirements are necessary 
for release of the T cell factor which induces IL-1 /3 
secretion from monocytes, indirect evidence suggests that it 
requires both TCR triggering plus costimulatory signals for 
its generation. 
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The ability to resolve early and late events during IL-
1 synthesis in these studies has enabled the identification 
of a T cell factor required for the secretion of IL-1 $ from 
monocytes. Thus, despite the presence of IL-1 $ mRNA 
transcripts in monocytes, secretion of IL-1 ~ requires the 
presence of a soluble T cell factor. This novel finding 
suggests that T cells regulate IL-1 ~ synthesis in monocytes 
at two discrete levels: At the level of initial induction of 
monocyte IL-1 mRNA and at the level of secretion of IL-1 $. 
In the final phase of this investigation, the cell 
surface molecules involved in transducing the initial IL-1 
mRNA triggering signal from T cells to monocytes during anti-
CD3 mitogenesis were studied. The possibility that triggering 
of IL-1 mRNA during an immune response occurred exclusively 
during an MHC class II restricted interaction between 
monocytes and CD4+ T cells was examined by comparing the IL-
1 inductive abilities of CD4+ and CDS+ T cells in the anti-CD3 
mitogenesis model. In these experiments, CD4+ and CDS+ T cell 
subpopulations isolated by negative and positive selection 
were evaluated for their IL-1 inductive abilities at the level 
of IL-1 mRNA and secreted IL-1 ~ respectively. 
Results show that CDS+ T cells are at least as potent 
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as CD4+ T cells in the induction of monocyte IL-1 rnRNAs and 
IL-1 ~ secretion. These results demonstrate that the IL-1 
inductive signal is not transduced exclusively during an MHC 
class II restricted interaction between monocytes and co4• T 
cells. Furthermore, these observations suggest that 
triggering of monocyte IL-1 mRNA during an immune response is 
either transduced by MHC non-restricted elements on the 
surface of T cells or can be transduced by both CD4 and CDS 
associative recognition elements. No hypothesis exists to 
suggest an in vivo role for cos• cells during the induction of 
IL-1 by monocytes. The possibility that induction of IL-1 is 
mediated by MHC non-restricted elements on the T cell surface 
is therefore favored as a more physiologically relevant 
interpretation of the observed results. These conclusions are 
the same as those previously reported by Wasik and Beller, who 
demonstrated that both class I restricted and class II 
restricted autoreactive T cell clones induced macrophage 
membrane IL-1 (108). These conclusions, however, are in 
contrast to another report in the literature, which concluded 
that alloreactive T cell clones induce intracellular monocyte 
IL-1 by "MHC-specific contact" with monocytes of the haplotype 
to which the clones were originally sensitized (109). The 
experimental system employed in reaching this conclusion, 
however, was unable to distinguish between events required for 
MHC restriction and those required for IL-1 triggering. 
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Inasmuch as it remained unclear from previous studies 
whether IL-1 inductive signals may be generated by unprimed 
T cells, purified naive and memory T cells were evaluated for 
their ability to induce IL-1 p secretion by monocytes during 
anti-CD3 mitogenesis. 
address the critical 
Studies with naive T cells directly 
question whether the initial IL-1 
triggering signal can be transduced by naive T cells in an 
experimental model of an afferent immune response. Results 
of these experiments show that virgin (CD45RA+) T cells are 
equally capable of inducing IL-1 p secretion by monocytes as 
memory (CD45RO+) T cells. These observations demonstrate that 
purified cells exhibiting a naive T cell phenotype are capable 
of transducing the initial IL-1 mRNA triggering signal to 
monocytes during anti-CD3 mitogenesis. These studies further 
show that induction of IL-1 is a feature of the afferent limb 
of the immune response. No previous report exists in the 
literature to address whether naive T cells in the afferent 
arm of the immune response are capable of generating an IL-1 
inductive signal. Previous studies have examined whether 
induction of IL-1 can be observed during primary and secondary 
polyclonal T cell responses. Based on a demonstration of IL-
1 induced during secondary but not primary polyclonal 
responses, previous authors have suggested that induction of 
IL-1 is a feature of the efferent but not afferent arm of the 
immune response (109, 138). However, in view of the fact that 
memory cells participate in mitogenic responses, these 
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previous reports did not, in fact, address whether induction 
of IL-1 occurred during the afferent arm of an immune 
response. The current investigation therefore provides the 
first evidence that IL-1 inductive signals can be transduced 
by virgin, unprimed T cells in an afferent model of an immune 
response. 
The mechanism by which the initial IL-1 mRNA inductive 
signal is transduced to the monocyte during antigen 
presentation is suggested by studies carried out in this 
investigation. Studies employing fixed T cells showed that 
T cells acquire a novel IL-1 inducing characteristic at the 
cell surface following activation through TCR triggering. 
Kinetic studies of IL-1 mRNA induced during anti-CD3 
mitogenesis show that acquisition of this cell surface entity 
is rapid, occurring at < 1 h. Furthermore, acquisition of 
this cell surface moiety does not require de nova protein 
synthesis. When considered together, these findings suggest 
a number of cell surface molecules through which T cells may 
trigger IL-1 mRNA in monocytes. In the absence of a de novo 
protein synthesis requirement, it must be proposed that the 
IL-1 inductive molecule exists at the surface of unactivated 
T cells. For signal transduction to occur the cell surface 
molecule subsequently requires either a conformational change 
induced by TCR/CD3 cross-linking or comigration with the 
TCR/CD3 complex to the site of monocyte-T cell contact. 
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A candidate molecule for the initial IL-1 mRNA 
inductive signal at the T cell surface is the T cell 
associative recognition element, CD4. According to the 
mechanism proposed, transduction of the IL-1 inductive signal 
may occur through the MHC class II molecule on monocytes 
following comigration of CD4 with the TCR/CDJ complex to the 
site of monocyte-T 
conformational change 
cell interaction 
induced by CD3/TCR 
or following 
cross-linking. 
Previous reports in the literature and preliminary studies 
contained in this report, suggested that MHC class II 
molecules could potentially act as IL-1 signalling molecules 
on monocytes, based on the ability of antibodies directed 
against these molecules to induce IL-1 synthesis (139, 140). 
However, experiments demonstrating that both CD4+ and CDS+ T 
cells could induce monocyte IL-1, argued either for the 
involvement of both CD4 and CDS molecules in the signal 
transduction or for the involvement of an MHC-unrestricted 
element. Inasmuch as no hypothesis exists to suggest an in 
vivo role for CDS+ cells during the induction of IL-1 by 
monocytes, these results favor the explanation that 
transduction of the IL-1 inductive signal involves a moiety 
other than an MHC molecule. Several other cell surface 
adhesion molecules may represent alternative candidate 
molecules, including the T cell/monocyte cell surface 
molecules CD2/LFA-3, LFA-1/ICAM-1 or LFA-1/ICAM-2. Indirect 
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evidence from the literature is consistent with the 
involvement of CD2 or LFA-1 T cell molecules in transduction 
of the IL-1 mRNA inductive signal. CD2 has been shown to be 
physically associated with the CD3/TCR complex and is 
therefore susceptible to potential conformational change 
following TCR triggering (141). LFA-1 has been shown to be 
rapidly converted from a low avidity to a high avidity form 
following TCR cross-linking, in a process that requires 
metabolic energy but no de !1QYQ protein synthesis (142). The 
high avidity form of LFA-1 is capable of binding transiently 
and reversibly to ICAM-1 on monocytes in a cycle of < l h 
duration. Transduction of an IL-1 mRNA inductive signal 
through LFA-1 is therefore consistent with a model of IL-1 
induction by T cells that involves cornigration or focussing 
of the IL-1 triggering entity at the site of monocyte-T cell 
contact. The alternative possibility exists that the IL-1 
triggering entity on the surface of T cells represents a 
hitherto undescribed cell surface molecule. 
A mechanism by which the second T cell IL-1 inductive 
signal, which is required for secretion of IL-1 {3 by 
monocytes, is transduced to the rnonocytes is suggested data 
obtained in this investigation. Secretion of IL-1 {3 by 
monocytes containing IL-1 {3 mRNA transcripts is dependent upon 
a T cell product which requires protein synthesis for. its 
generation. Previous reports have demonstrated that secretion 
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of IL-1 f3 from the intracellular 31 kD precursor pool in 
monocytes is dependent upon proteolytic cleavage by a serine 
protease (59, 143). The T cell factor may therefore induce 
release of mature IL-1 f3 by stimulating the production or 
activity of the serine protease processing enzyme in 
monocytes. 
The proposed mechanism by which IL-1 f3 secretion is 
induced by the T cell factor may also explain how LPS or 
phagocytic stimuli are capable of inducing IL-1 f3 secretion 
by monocytes in the absence of T cell products. Previous 
observations have demonstrated that bacterial products and 
particulate antigens have an intrinsic ability to stimulate 
intracellular monocyte proteases (144). It was interesting 
to note from the present studies that despite inducing higher 
levels of IL-1 f3 mRNA in all experiments, LPS was less 
effective than the anti-CD3 stimulus at inducing IL-1 f3 
secretion. These results suggest that secretion of IL-1 f3 by 
monocytes is more efficient in the presence of activated T 
cell products. An implication of the proposed mechanism 
governing IL-1 secretion from monocytes, is that effective 
secretion of IL-1 f3, regardless of the nature of the IL-1 mRNA 
triggering stimulus, requires the recruitment of activated T 
cells and their products. 
Based on the results contained in this report, a brief 
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model of IL-1 induction during an immune response may be 
proposed. T cells are initially triggered through their TCR 
by recognition of specific foreign antigen expressed in 
conjunction with self class II MHC molecules on the surface 
of monocytes. Within 1 h following triggering, T cells 
transduce a cell contact mediated IL-1 mRNA inductive signal 
to the monocyte participating in the antigen specific T cell-
monocyte interaction. This IL-1 mRNA inductive property is 
acquired at the cell surface of triggered T cells in the 
absence of de novo protein synthesis. Initial induction of 
monocyte IL-1 mRNA occurs in the absence of soluble T cell 
signals. Monocyte IL-1 a and IL-1 ~ genes are transcribed, 
specific mRNAs are translated and a fraction of immature 
cytoplasmic IL-1 precursors are translocated to the exterior 
cell membrane of monocytes, with little or no concomitant 
secretion of IL-1. Appropriately triggered T cells initially 
receive IL-1 costimulatory signals, either in the form of 
membrane IL-1 or in the form of modest levels of secreted IL-
1. IL-1 may exert its costimulatory properties in synergy 
with IL-6 and other monocyte derived soluble or cell 
associated costimulatory molecules. T cells that have 
received the necessary costimulatory signals elaborate IL-2 
and other late phase lymphokines which by themselves possess 
IL-1 inducing properties. The major phase of IL-1 ~ secretion 
by monocytes requires the presence of a T cell factor that is 
dependent upon de novo protein synthesis for its generation. 
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This T cell factor is most probably a soluble lyrnphokine, or 
combination of lyrnphokines. Multiple late phase lyrnphokines 
with IL-1 inducing properties participate in an amplification 
loop, in which initially modest levels of late phase 
lymphokines induce the secretion of IL-1 by monocytes, thereby 
further activating T cells and enhancing additional secretion 
of late phase lyrnphokines. Steady state levels of monocyte 
IL-1 rnRNAs are maintained by soluble IL-1 mRNA inductive or 
augmenting cytokines generated during the course of an immune 
response. These IL-1 inducing cytokines induce further IL-1 
production non-specifically in bystander monocytes during the 
immune response. 
This investigation has identified novel T cell mediated 
signals that regulate two important stages of IL-1 synthesis 
by human blood monocytes during an immune response. First, 
a T cell signal that initiates induction of monocyte IL-1 
mRNAs through direct cell contact. Second, a soluble T cell 
factor that is required for secretion of IL-1 ~ from 
monocytes. During the initial phase of an immune challenge, 
unprimed T cells provide the specificity of the IL-1 response 
to soluble antigen by transducing a rapid IL-1 mRNA inductive 
signal to monocytes participating in an antigen specific 
interaction with T cells. At a subsequent stage of the immune 
response, activated T cells amplify this specifically induced 
IL-1 response at multiple levels, including induced IL-1 
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secretion by monocytes, maintenance of steady state IL-1 mRNA 
levels and induced IL-1 production by antigen non-specific 
monocytes. In humans, T cells therefore control both the 
specificity and the amplitude of IL-1 synthesized by monocytes 
in response to an immune challenge. 
SUMMARY 
1. Freshly isolated human blood monocytes expressed IL-1 a 
and ~ mRNA immediately prior to adherence, which peaked 
at 12 h following adherence to plastic culture plates and 
diminished to undetectable IL-1 mRNA levels at 48 h of 
adherence. 
2 . I L-1 a and ~ mRNAs were induced in 4 8 h adherent 
monocytes following the addition of T cells plus anti-
CD3 antibody, but not following T cells or anti-CD3 
alone. A non-mitogenic anti-CDS antibody, of the same 
isotype as anti-CD3, was incapable of providing the 
necessary stimulus for the induction of monocyte IL-1 
mRNAs in the presence of T cells. Monocyte IL-1 a and 
~ mRNAs were detectable as early as 1 h following the 
addition of T cells plus anti-CD3, peaked at 12 h and 
declined by 24 h. Induction of IL-1 mRNA during anti-
CD3 mitogenesis was confined exclusively to the monocyte 
population: no IL-1 mRNA was detected in the activated 
T cell population. 
3. Similar induction kinetics for IL-1 a and IL-1 ~ mRNA 
were observed throughout this investigation. Relative 
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to LPS inducible levels for each IL-1 species, levels of 
IL-1 a mRNA induced during anti-CD3 mitogenesis were 
greater than relative levels of IL-1 ~ mRNA. 
4. Induction of monocyte IL-1 mRNA during anti-CD3 
mitogenesis was associated with secreted IL-1 ~' but not 
IL-1 a, which was detectable as early as 4 h and reaching 
maximum levels at 48 h. Biologic activity was detectable 
at 12 h, the earliest time point tested, and attained 
maximal levels at 48 h of study. 
5. IL-6 mRNA was coinduced with IL-1 mRNA in monocytes 
during anti-CD3 mitogenesis. 
6. IL-1 synthesis was induced in monocytes during the 
primary allogeneic mixed lymphocyte response. 
7. The initial and major phase of induction of monocyte IL-
1 mRNA occurred in the presence of cell contact with T 
cells plus anti-CD3. A later, low level of induction of 
IL-1 mRNA occurred in monocytes receiving only soluble 
factors generated during anti-CD3 mitogenesis. 
8. Induction of the late phase of IL-1 mRNA in monocytes, 
which occurred independently of contact with T cells, was 
temporally associated with the appearance of the IL-1 
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inducing cytokines, IL-2, IFN-¥, and TNF-Q in anti-CD3 
mitogenic culture supernates. 
9. Metabolically inactivated T cells were capable of 
inducing IL-1 mRNAs in monocytes, but only if T cells had 
been preactivated. Metabolic activity by T cells was 
required for the secretion of IL-1 p by monocytes. 
10. Induction of monocyte IL-1 mRNA during anti-CD3 
mitogenesis occurred independently of de novo protein 
synthesis by T cells,although de novo protein synthesis 
was required by T cells for secretion of IL-1 p by 
monocytes. 
11. Induction of IL-1 synthesis in monocytes during anti-CD3 
mitogenesis was mediated equally well by both MHC class 
II restricted (CD4+) and MHC class I restricted (CDS+) T 
cells and by both naive (CD45RA+) and memory (CD45RO+) T 
cells during anti-CD3 mitogenesis. 
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Figure 1. Flow Cytometric contour Plots Depicting CD14, HLA-
DR and CD2 Cell surface Marker Expression by Monocyte and T 
Cell Populations Purified from PBMCs Monocyte and T cell 
populations isolated from PBMCs were labelled with anti-HLA-
DR (PE anti-HLA-DR), anti-CD14 (PE anti-Leu M3) and anti-CD2 
(FITC anti-Leu 5) antibodies and analyzed by flow cytometry. 
Figure depicts flow cytometric contour plots from a 
representative experiment. 
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Figure 2. Flow Cytometric Contour Plots Depicting CD14, HLA-
DR and CD2 cell surface Marker Expression by Monocyte and T 
Cell Populations Isolated From Anti-CD3 Mitogenic Cultures 
Monocytes isolated from the adherent fraction of anti-CD3 
mitogenesis cultures were depleted of contaminating T cell 
blasts by anti-CD3 dependent complement mediated lysis. Final 
monocyte populations were analyzed in the presence of PI to 
exclude non-viable cells from analysis. T cells were isolated 
from the non-adherent cell fraction by rosetting with AET 
treated SRBC. Resultant cell populations were labelled with 
anti-HLA-DR (PE anti-HLA-DR), anti-CD14 (PE anti-Leu M3) and 
anti-CD2 (FITC anti-Leu 5) antibodies and presented as flow 
cytometric contour plots. 
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Figure 3. Flow cytometric Histograms Depicting CD3 and CDB 
Cell surface Marker Expression and PI Uptake by Fixed and 
Unfixed T Cells Fixed and unfixed unstimulated T cells were 
stained with PI or anti-CD3 (FITC anti-Leu 4) and anti-CDS (PE 
anti-Leu 2a) antibodies and analyzed by flow cytometry. T 
cells shown in this figure were employed in the fixation 
studies investigating monocyte IL-1 mRNA induction by fixed 
T cells, depicted in Figure 12. 
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Figure 4. Flow Cytometric Histograms Depicting CD3 and CDS 
Cell Surface Marker Expression and PI Uptake by Fixed and 
Unfixed T Cells Fixed T cells, preactivated with immobilized 
anti-CD3 (Group 1) or monocytes plus anti-CD3 (Group 3), were 
stained with PI or anti-CD3 (FITC anti-Leu 4) and anti-CDS (PE 
anti-Leu 2a) antibodies and analyzed by flow cytometry. T 
cells shown in this figure were employed in the fixation 
studies investigating monocyte IL-1 mRNA induction by fixed 
T cells, depicted in Figure 12. 
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Figure s. Flow cytometric Contour Plots Depicting CD4 and 
CDS Cell surface Marker Expression by T Cell Subpopulations 
Obtained by Negative Selection T cells, separated into CD4+ 
and CDS+ enriched T cell subpopulations by negative selection, 
were labelled with anti-CD4 (FITC anti-Leu 3a&b) and anti-CDS 
(PE anti-Leu 2a) antibodies and analyzed by flow cytometry. 
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Figure 6. Flow cytometric contour Plots Depicting CD4, CDS, 
CD4SRA and CD4SRO Cell surface Marker Expression by T Cell 
Subpopulations Obtained by Positive Selection T cells, 
labelled with anti-CD4 (FITC anti-Leu 3a&b) plus anti-CDS (PE 
anti-Leu 2a) antibodies (panel A.) or anti-CD45RA (FITC anti-
Leu 18) plus anti-CD45RO (PE UCHL-1) antibodies (panel D.), 
were sorted into co4• (Panel B.), cos• (C.), CD45RA+ (E.) and 
CD45RO+ (F.) T cell subpopulations. Figure depicts flow 
cytornetric contour plots from a representative experiment. 
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